BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dangas G, Iakovou I, Nikolsky E, Aymong ED, Mintz GS, Kipshidze NN, Lansky AJ, Moussa I, Stone GW, Moses JW, Leon MB, Mehran R. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol. 2005;95:13-19. [PMID: 15619387 DOI: 10.1016/j.amjcard.2004.08.056] [Cited by in Crossref: 379] [Cited by in F6Publishing: 315] [Article Influence: 22.3] [Reference Citation Analysis]
Number Citing Articles
1 Eggebrecht H, Breuckmann F, Martini S, Baumgart D, Herold U, Kienbaum P, Peters J, Jakob H, Erbel R, Mehta RH. Frequency and Outcomes of Acute Renal Failure Following Thoracic Aortic Stent-Graft Placement. The American Journal of Cardiology 2006;98:458-63. [DOI: 10.1016/j.amjcard.2006.02.052] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
2 Hernando L, Canovas E, Freites A, de la Rosa A, Alonso J, del Castillo R, Salinas P, Montalvo GB, Huelmos AI, Botas J. Prevalence and Prognosis of Percutaneous Coronary Intervention-associated Nephropathy in Patients With Acute Coronary Syndrome and Normal Kidney Function. Revista Española de Cardiología (English Edition) 2015;68:310-6. [DOI: 10.1016/j.rec.2014.04.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
3 Isaka Y, Hayashi H, Aonuma K, Horio M, Terada Y, Doi K, Fujigaki Y, Yasuda H, Sato T, Fujikura T, Kuwatsuru R, Toei H, Murakami R, Saito Y, Hirayama A, Murohara T, Sato A, Ishii H, Takayama T, Watanabe M, Awai K, Oda S, Murakami T, Yagyu Y, Joki N, Komatsu Y, Miyauchi T, Ito Y, Miyazawa R, Kanno Y, Ogawa T, Hayashi H, Koshi E, Kosugi T, Yasuda Y; Japanese Society of Nephrology, Japan Radiological Society, and Japanese Circulation Society Joint Working Group. Guideline on the use of iodinated contrast media in patients with kidney disease 2018. Jpn J Radiol 2020;38:3-46. [PMID: 31709498 DOI: 10.1007/s11604-019-00850-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Berwanger O, Cavalcanti AB, Sousa AM, Buehler A, Castello-Júnior HJ, Cantarelli MJ, Mangione JA, Bergo RR, São Thiago LE, Nunes PM, da Motta PA, Kodama A, Victor E, Carvalho VO, Sousa JE; Acetylcysteine for Contrast-Induced Nephropathy Trial Investigators. Acetylcysteine for the prevention of renal outcomes in patients with diabetes mellitus undergoing coronary and peripheral vascular angiography: a substudy of the acetylcysteine for contrast-induced nephropathy trial. Circ Cardiovasc Interv 2013;6:139-45. [PMID: 23572490 DOI: 10.1161/CIRCINTERVENTIONS.112.000149] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
5 Sedlis SP, Jurkovitz CT, Hartigan PM, Goldfarb DS, Lorin JD, Dada M, Maron DJ, Spertus JA, Mancini GJ, Teo KK, O'rourke RA, Boden WE, Weintraub WS. Optimal Medical Therapy With or Without Percutaneous Coronary Intervention for Patients With Stable Coronary Artery Disease and Chronic Kidney Disease. The American Journal of Cardiology 2009;104:1647-53. [DOI: 10.1016/j.amjcard.2009.07.043] [Cited by in Crossref: 75] [Cited by in F6Publishing: 57] [Article Influence: 5.8] [Reference Citation Analysis]
6 Pradhan J, Niraj A, Afonso L. Determinants of amount of contrast utilized in patients undergoing percutaneous coronary procedures. Coronary Artery Disease 2007;18:275-82. [DOI: 10.1097/mca.0b013e328056dd46] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Oguzhan N, Cilan H, Sipahioglu M, Unal A, Kocyigit I, Kavuncuoglu F, Arikan T, Akpek M, Elcik D, Sahin O, Gulme E, Pala C, Tokgoz B, Utas C, Oguzhan A, Oymak O. The Lack of Benefit of a Combination of an Angiotensin Receptor Blocker and Calcium Channel Blocker on Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease. Renal Failure 2013;35:434-9. [DOI: 10.3109/0886022x.2013.766566] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
8 Schneider A, Gallaher J, Purcell LN, Raff L, Eckert M, Charles A. Risk of acute kidney injury requiring hemodialysis after contrast-enhanced imaging after traumatic injury: A National Trauma Databank analysis. Surgery 2021:S0039-6060(21)00878-3. [PMID: 34711427 DOI: 10.1016/j.surg.2021.08.056] [Reference Citation Analysis]
9 Hölscher B, Heitmeyer C, Fobker M, Breithardt G, Schaefer RM, Reinecke H. Predictors for contrast media-induced nephropathy and long-term survival: prospectively assessed data from the randomized controlled Dialysis-Versus-Diuresis (DVD) trial. Can J Cardiol. 2008;24:845-850. [PMID: 18987758 DOI: 10.1016/s0828-282x(08)70193-4] [Cited by in Crossref: 31] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
10 Liu Y, Liu YH, Chen JY, Tan N, Zhou YL, Duan CY, Yu DQ, Xie NJ, Li HL, Chen PY. Safe contrast volumes for preventing contrast-induced nephropathy in elderly patients with relatively normal renal function during percutaneous coronary intervention. Medicine (Baltimore). 2015;94:e615. [PMID: 25816028 DOI: 10.1097/md.0000000000000615] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
11 Tan N, Liu Y, Zhou YL, He PC, Yang JQ, Luo JF, Chen JY. Contrast medium volume to creatinine clearance ratio: a predictor of contrast-induced nephropathy in the first 72 hours following percutaneous coronary intervention. Catheter Cardiovasc Interv. 2012;79:70-75. [PMID: 21990069 DOI: 10.1002/ccd.23048] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
12 Yang Y, George KC, Luo R, Cheng Y, Shang W, Ge S, Xu G. Contrast-induced acute kidney injury and adverse clinical outcomes risk in acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis. BMC Nephrol 2018;19:374. [PMID: 30577763 DOI: 10.1186/s12882-018-1161-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
13 Yang R, Chang L, Guo BY, Wang YW, Wang YL, Jin X, Liu SY, Li YJ. Compound danshen dripping pill pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Evid Based Complement Alternat Med 2014;2014:256268. [PMID: 25386219 DOI: 10.1155/2014/256268] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
14 Hipp A, Desai S, Lopez C, Sinert R. The incidence of contrast-induced nephropathy in trauma patients. Eur J Emerg Med 2008;15:134-9. [PMID: 18460952 DOI: 10.1097/MEJ.0b013e328270367d] [Cited by in Crossref: 41] [Cited by in F6Publishing: 8] [Article Influence: 2.9] [Reference Citation Analysis]
15 Stephan T, Felbel D, Rattka M, Rottbauer W, Markovic S. Impact of radial access on contrast-induced acute kidney injury in patients with coronary artery bypass grafts. Cardiovasc Revasc Med 2021:S1553-8389(21)00214-1. [PMID: 33992588 DOI: 10.1016/j.carrev.2021.04.026] [Reference Citation Analysis]
16 Cho MH, Kim SN, Park HW, Chung S, Kim KS. Could Vitamin E Prevent Contrast-Induced Acute Kidney Injury? A Systematic Review and Meta-Analysis. J Korean Med Sci 2017;32:1468-73. [PMID: 28776342 DOI: 10.3346/jkms.2017.32.9.1468] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
17 Wong PC, Guo J, Zhang A. A hypothesis on the conflicting results of angiotensin converting enzyme inhibitor in the prevention of contrast-induced nephropathy. Med Hypotheses 2015;85:874-7. [PMID: 26432630 DOI: 10.1016/j.mehy.2015.09.020] [Reference Citation Analysis]
18 Downes M. Introduction. Cardiovasc Intervent Radiol 2005;28:S1-2. [DOI: 10.1007/s00270-005-0198-6] [Reference Citation Analysis]
19 Sato A, Aonuma K, Watanabe M, Hirayama A, Tamaki N, Tsutsui H, Toyoaki M, Ogawa H, Akasaka T, Yoshimura M, Takayama T, Sakakibara M, Suzuki S, Ishigami K, Onoue K, Saito Y; CINC-J study investigators. Association of contrast-induced nephropathy with risk of adverse clinical outcomes in patients with cardiac catheterization: From the CINC-J study. Int J Cardiol 2017;227:424-9. [PMID: 27838134 DOI: 10.1016/j.ijcard.2016.11.019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
20 Sterner G, Nyman U. Contrast medium-induced nephropathy. Aspects on incidence, consequences, risk factors and prevention. Libyan Journal of Medicine 2016;2:118-24. [DOI: 10.3402/ljm.v2i3.4710] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
21 Davidson C, Stacul F, McCullough PA, Tumlin J, Adam A, Lameire N, Becker CR; CIN Consensus Working Panel. Contrast medium use. Am J Cardiol 2006;98:42K-58K. [PMID: 16949380 DOI: 10.1016/j.amjcard.2006.01.023] [Cited by in Crossref: 125] [Cited by in F6Publishing: 103] [Article Influence: 7.8] [Reference Citation Analysis]
22 Ohno I, Hayashi H, Aonuma K, Horio M, Kashihara N, Okada H, Komatsu Y, Tamura S, Awai K, Yamashita Y, Kuwatsuru R, Hirayama A, Saito Y, Murohara T, Tamaki N, Sato A, Takayama T, Imai E, Yasuda Y, Koya D, Tsubakihara Y, Horie S, Korogi Y, Narumi Y, Hayakawa K, Daida H, Node K, Kubota I. Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version: JSN, JRS, and JCS Joint Working Group. Clin Exp Nephrol 2013;17:441-79. [DOI: 10.1007/s10157-013-0843-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
23 Hoste EA, Doom S, De Waele J, Delrue LJ, Defreyne L, Benoit DD, Decruyenaere J. Epidemiology of contrast-associated acute kidney injury in ICU patients: a retrospective cohort analysis. Intensive Care Med 2011;37:1921-31. [PMID: 22048719 DOI: 10.1007/s00134-011-2389-8] [Cited by in Crossref: 55] [Cited by in F6Publishing: 45] [Article Influence: 5.0] [Reference Citation Analysis]
24 Wu X, Ma C, Sun D, Zhang G, Wang J, Zhang E. Inflammatory Indicators and Hematological Indices in Contrast-Induced Nephropathy Among Patients Receiving Coronary Intervention: A Systematic Review and Meta-Analysis. Angiology 2021;72:867-77. [PMID: 33719591 DOI: 10.1177/00033197211000492] [Reference Citation Analysis]
25 Goldfarb S, Mccullough PA, Mcdermott J, Gay SB. Contrast-Induced Acute Kidney Injury: Specialty-Specific Protocols for Interventional Radiology, Diagnostic Computed Tomography Radiology, and Interventional Cardiology. Mayo Clinic Proceedings 2009;84:170-9. [DOI: 10.4065/84.2.170] [Cited by in Crossref: 98] [Cited by in F6Publishing: 48] [Article Influence: 7.5] [Reference Citation Analysis]
26 Traub SJ, Kellum JA, Tang A, Cataldo L, Kancharla A, Shapiro NI. Risk factors for radiocontrast nephropathy after emergency department contrast-enhanced computerized tomography. Acad Emerg Med 2013;20:40-5. [PMID: 23570477 DOI: 10.1111/acem.12059] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
27 Toprak O, Cirit M. Risk factors for contrast-induced nephropathy. Kidney Blood Press Res. 2006;29:84-93. [PMID: 16707906 DOI: 10.1159/000093381] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 2.4] [Reference Citation Analysis]
28 McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, Tumlin J; CIN Consensus Working Panel. Risk prediction of contrast-induced nephropathy. Am J Cardiol. 2006;98:27K-36K. [PMID: 16949378 DOI: 10.1016/j.amjcard.2006.01.022] [Cited by in Crossref: 261] [Cited by in F6Publishing: 218] [Article Influence: 16.3] [Reference Citation Analysis]
29 Ribichini F, Graziani M, Gambaro G, Pasoli P, Pighi M, Pesarini G, Abaterusso C, Yabarek T, Brunelleschi S, Rizzotti P. Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. Am J Med. 2010;123:755-763. [PMID: 20670731 DOI: 10.1016/j.amjmed.2010.02.026] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
30 Bentley ML. Acute kidney insufficiency in the critically ill. J Pharm Pract 2011;24:61-9. [PMID: 21507875 DOI: 10.1177/0897190010388155] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
31 Ishibashi Y, Yamauchi M, Musha H, Mikami T, Kawasaki K, Miyake F. Impact of Contrast-Induced Nephropathy and Cardiovascular Events by Serum Cystatin C in Renal Insufficiency Patients Undergoing Cardiac Catheterization. Angiology 2010;61:724-30. [DOI: 10.1177/0003319710379108] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
32 Onuigbo MA, Onuigbo NT. Does renin-angiotensin aldosterone system blockade exacerbate contrast-induced nephropathy in patients with chronic kidney disease? A prospective 50-month Mayo Clinic study. Ren Fail 2008;30:67-72. [PMID: 18197546 DOI: 10.1080/08860220701742153] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
33 Giacoppo D, Madhavan MV, Baber U, Warren J, Bansilal S, Witzenbichler B, Dangas GD, Kirtane AJ, Xu K, Kornowski R, Brener SJ, Généreux P, Stone GW, Mehran R. Impact of Contrast-Induced Acute Kidney Injury After Percutaneous Coronary Intervention on Short- and Long-Term Outcomes: Pooled Analysis From the HORIZONS-AMI and ACUITY Trials. Circ Cardiovasc Interv 2015;8:e002475. [PMID: 26198286 DOI: 10.1161/CIRCINTERVENTIONS.114.002475] [Cited by in Crossref: 77] [Cited by in F6Publishing: 28] [Article Influence: 12.8] [Reference Citation Analysis]
34 Kaye DM, Stub D, Mak V, Doan T, Duffy SJ. Reducing iodinated contrast volume by manipulating injection pressure during coronary angiography: Reducing Radiographic Iodinated Contrast Volume. Cathet Cardiovasc Intervent 2014;83:741-5. [DOI: 10.1002/ccd.25348] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
35 Pyka Ł, Hawranek M, Wilczek K, Piegza J, Szkodzinski J, Lekston A, Gąsior M. Imaging-guided percutaneous coronary intervention with ultra-low contrast angiographic control for patients at extreme risk of contrast induced nephropathy. Cardiol J 2019;26:796-8. [PMID: 31970738 DOI: 10.5603/CJ.2019.0117] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Song T, Song M, Ge Z, Li Y, Shi P, Sun M. Comparison of the nephrotoxic effects of iodixanol versus iohexol in patients with chronic heart failure undergoing coronary angiography or angioplasty. J Interv Cardiol 2017;30:281-5. [PMID: 28421628 DOI: 10.1111/joic.12381] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
37 Zhao S, Zhong Z, Qi G, Tian W. The efficacy of N-acetylcysteine plus sodium bicarbonate in the prevention of contrast-induced nephropathy after cardiac catheterization and percutaneous coronary intervention: A meta-analysis of randomized controlled trials. International Journal of Cardiology 2016;221:251-9. [DOI: 10.1016/j.ijcard.2016.07.086] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
38 Zahler D, Rozenfeld KL, Merdler I, Peri Y, Shacham Y. Contrast Volume to Glomerular Filtration Ratio and Acute Kidney Injury among ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention. Cardiorenal Med 2020;10:108-15. [PMID: 31801134 DOI: 10.1159/000504534] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
39 Wang Y, Bolen M, Sydow G, Kottha A, Soufan K, Bullen J, Kemper C, Kalafut J, Halliburton SS. Adaptation of contrast injection protocol to tube potential for cardiovascular CT. AJR Am J Roentgenol 2014;203:1181-91. [PMID: 25415695 DOI: 10.2214/AJR.13.12013] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
40 Li WH, Li DY, Han F, Xu TD, Zhang YB, Zhu H. Impact of anemia on contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary interventions. Int Urol Nephrol 2013;45:1065-70. [PMID: 23225080 DOI: 10.1007/s11255-012-0340-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
41 Gallagher S, Kapur A, Lovell MJ, Jones DA, Kirkwood A, Hassan S, Archbold RA, Wragg A, Uppal R, Yaqoob MM. Impact of diabetes mellitus and renal insufficiency on 5-year mortality following coronary artery bypass graft surgery: a cohort study of 4869 UK patients. European Journal of Cardio-Thoracic Surgery 2014;45:1075-81. [DOI: 10.1093/ejcts/ezt630] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
42 Koo HM, Doh FM, Ko KI, Kim CH, Lee MJ, Oh HJ, Han SH, Kim BS, Yoo TH, Kang SW, Choi KH. Diastolic dysfunction is associated with an increased risk of contrast-induced nephropathy: a retrospective cohort study. BMC Nephrol 2013;14:146. [PMID: 23849485 DOI: 10.1186/1471-2369-14-146] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
43 Leistner DM, Dietrich S, Erbay A, Steiner J, Abdelwahed Y, Siegrist PT, Schindler M, Skurk C, Haghikia A, Sinning D, Riedel M, Landmesser U, Stähli BE. Association of left ventricular end‐diastolic pressure with mortality in patients undergoing percutaneous coronary intervention for acute coronary syndromes. Catheter Cardiovasc Interv 2020;96. [DOI: 10.1002/ccd.28839] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Aguiar-souto P, Ferrante G, Del Furia F, Barlis P, Khurana R, Di Mario C. Frequency and predictors of contrast-induced nephropathy after angioplasty for chronic total occlusions. International Journal of Cardiology 2010;139:68-74. [DOI: 10.1016/j.ijcard.2008.10.006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
45 Ren HM, Wang X, Hu CY, Que B, Ai H, Wang CM, Sun LZ, Nie SP. Relationship between acute kidney injury before thoracic endovascular aneurysm repair and in-hospital outcomes in patients with type B acute aortic dissection. J Geriatr Cardiol 2015;12:232-8. [PMID: 26089846 DOI: 10.11909/j.issn.1671-5411.2015.03.002] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
46 Liu Y, Chen JY, Tan N, Zhou YL, Yu DQ, Chen ZJ, He YT, Liu YH, Luo JF, Huang WH, Li G, He PC, Yang JQ, Xie NJ, Liu XQ, Yang DH, Huang SJ, Piao-Ye, Li HL, Ran P, Duan CY, Chen PY. Safe limits of contrast vary with hydration volume for prevention of contrast-induced nephropathy after coronary angiography among patients with a relatively low risk of contrast-induced nephropathy. Circ Cardiovasc Interv 2015;8:e001859. [PMID: 26041500 DOI: 10.1161/CIRCINTERVENTIONS.114.001859] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
47 James MT, Ghali WA, Knudtson ML, Ravani P, Tonelli M, Faris P, Pannu N, Manns BJ, Klarenbach SW, Hemmelgarn BR. Associations Between Acute Kidney Injury and Cardiovascular and Renal Outcomes After Coronary Angiography. Circulation 2011;123:409-16. [DOI: 10.1161/circulationaha.110.970160] [Cited by in Crossref: 229] [Cited by in F6Publishing: 95] [Article Influence: 20.8] [Reference Citation Analysis]
48 Lockhart ME, Robbin ML. Renal vascular imaging: ultrasound and other modalities. Ultrasound Q 2007;23:279-92. [PMID: 18090838 DOI: 10.1097/ruq.0b013e31815adf4c] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
49 Laskey WK, Jenkins C, Selzer F, Marroquin OC, Wilensky RL, Glaser R, Cohen HA, Holmes DR; NHLBI Dynamic Registry Investigators. Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention. J Am Coll Cardiol. 2007;50:584-590. [PMID: 17692741 DOI: 10.1016/j.jacc.2007.03.058] [Cited by in Crossref: 244] [Cited by in F6Publishing: 195] [Article Influence: 16.3] [Reference Citation Analysis]
50 Liu W, Ming Q, Shen J, Wei Y, Li W, Chen W, Xu Y. Trimetazidine Prevention of Contrast-Induced Nephropathy in Coronary Angiography. The American Journal of the Medical Sciences 2015;350:398-402. [DOI: 10.1097/maj.0000000000000575] [Cited by in Crossref: 18] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
51 Rencuzogullari I, Çağdaş M, Karakoyun S, Karabağ Y, Yesin M, Gürsoy MO, Artaç İ, İliş D, Efe SÇ, Tural K, Tanboğa IH. Association of Syntax Score II with Contrast-induced Nephropathy and Hemodialysis Requirement in Patients with ST Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Korean Circ J 2018;48:59-70. [PMID: 29171203 DOI: 10.4070/kcj.2017.0058] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
52 Galassi A, Grantham A, Kandzari D, Lombardi W, Moussa I, Thompson C, Werner G, Chambers C, Brilakis E. Percutaneous Treatment of Coronary Chronic Total Occlusion Part 2: Technical Approach. Interv Cardiol 2014;9:201-7. [PMID: 29588803 DOI: 10.15420/icr.2014.9.3.201] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
53 Kalb B, Martin DR, Salman K, Sharma P, Votaw J, Larsen C. Kidney transplantation: structural and functional evaluation using MR Nephro-Urography. J Magn Reson Imaging. 2008;28:805-822. [PMID: 18821623 DOI: 10.1002/jmri.21562] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
54 Abu Jawdeh BG, Leonard AC, Sharma Y, Katipally S, Shields AR, Alloway RR, Woodle ES, Thakar CV. Contrast-Induced Nephropathy in Renal Transplant Recipients: A Single Center Experience. Front Med (Lausanne) 2017;4:64. [PMID: 28603715 DOI: 10.3389/fmed.2017.00064] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
55 Reddan D. Patients at high risk of adverse events from intravenous contrast media after computed tomography examination. European Journal of Radiology 2007;62:26-32. [DOI: 10.1016/j.ejrad.2007.02.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
56 Balemans CE, Reichert LJ, van Schelven BI, van den Brand JA, Wetzels JF. Epidemiology of contrast material-induced nephropathy in the era of hydration. Radiology. 2012;263:706-713. [PMID: 22535561 DOI: 10.1148/radiol.12111667] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 5.3] [Reference Citation Analysis]
57 Kuboyama O, Tokunaga T. The prevalence and prognosis of contrast-induced acute kidney injury according to the definition in patients with acute myocardial infarction who underwent primary percutaneous coronary intervention. Clinical Trials and Regulatory Science in Cardiology 2016;13:29-33. [DOI: 10.1016/j.ctrsc.2015.11.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
58 Nakahashi H, Kosuge M, Sakamaki K, Kiyokuni M, Ebina T, Hibi K, Tsukahara K, Iwahashi N, Kuji S, Oba MS, Umemura S, Kimura K. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention. Heart Vessels 2017;32:22-9. [PMID: 27106917 DOI: 10.1007/s00380-016-0836-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
59 Navaneethan SD, Singh S, Appasamy S, Wing RE, Sehgal AR. Sodium Bicarbonate Therapy for Prevention of Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis. American Journal of Kidney Diseases 2009;53:617-27. [DOI: 10.1053/j.ajkd.2008.08.033] [Cited by in Crossref: 147] [Cited by in F6Publishing: 108] [Article Influence: 11.3] [Reference Citation Analysis]
60 Reddan D, Fishman EK. Radiologists’ knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: A survey of European radiologists. European Journal of Radiology 2008;66:235-45. [DOI: 10.1016/j.ejrad.2007.05.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
61 Meloni M, Giurato L, Izzo V, Stefanini M, Gandini R, Uccioli L. Risk of contrast induced nephropathy in diabetic patients affected by critical limb ischemia and diabetic foot ulcers treated by percutaneous transluminal angioplasty of lower limbs. Diabetes Metab Res Rev. 2017;33. [PMID: 27786404 DOI: 10.1002/dmrr.2866] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
62 Feldkamp T, Luedemann M, Spehlmann ME, Freitag-Wolf S, Gaensbacher J, Schulte K, Bajrovic A, Hinzmann D, Hippe HJ, Kunzendorf U, Frey N, Luedde M. Radial access protects from contrast media induced nephropathy after cardiac catheterization procedures. Clin Res Cardiol 2018;107:148-57. [PMID: 28939956 DOI: 10.1007/s00392-017-1166-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
63 Kunadian V, Zaman A, Spyridopoulos I, Qiu W. Sodium bicarbonate for the prevention of contrast induced nephropathy: a meta-analysis of published clinical trials. Eur J Radiol. 2011;79:48-55. [PMID: 20074886 DOI: 10.1016/j.ejrad.2009.12.015] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
64 Liu L, Liu J, Lei L, Wang B, Sun G, Guo Z, He Y, Song F, Lun Z, Liu B, Chen G, Chen S, Yang Y, Liu Y, Chen J. A prediction model of contrast-associated acute kidney injury in patients with hypoalbuminemia undergoing coronary angiography. BMC Cardiovasc Disord 2020;20:399. [PMID: 32867690 DOI: 10.1186/s12872-020-01689-6] [Reference Citation Analysis]
65 Lee MJ, Park JS, Kim HH. Diastolic dysfunction is associated with an increased risk of postcontrast acute kidney injury. Medicine (Baltimore) 2019;98:e17994. [PMID: 31770210 DOI: 10.1097/MD.0000000000017994] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
66 He HM, Zhang SC, He C, You ZB, Luo MQ, Lin MQ, Lin XQ, Zhang LW, Lin KY, Guo YS. Association between neutrophil percentage-to-albumin ratio and contrast-associated acute kidney injury in patients without chronic kidney disease undergoing percutaneous coronary intervention. J Cardiol 2021:S0914-5087(21)00238-0. [PMID: 34551865 DOI: 10.1016/j.jjcc.2021.09.004] [Reference Citation Analysis]
67 Yang JQ, Ran P, Chen JY, He YT, Li LW, Tan N, Li G, Sun S, Liu Y, Zhan JX, Zheng JY, Zhou YL. Development of contrast-induced acute kidney injury after elective contrast media exposure in patients with type 2 diabetes mellitus: effect of albuminuria. PLoS One 2014;9:e106454. [PMID: 25192238 DOI: 10.1371/journal.pone.0106454] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
68 Garcia S, Ko B, Adabag S. Contrast-Induced Nephropathy and Risk of Acute Kidney Injury and Mortality After Cardiac Operations. The Annals of Thoracic Surgery 2012;94:772-6. [DOI: 10.1016/j.athoracsur.2012.04.089] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
69 Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, Kosiborod M, Amin AP, Weintraub WS, Curtis JP, Messenger JC, Rumsfeld JS, Spertus JA. Validated contemporary risk model of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the National Cardiovascular Data Registry Cath-PCI Registry. J Am Heart Assoc 2014;3:e001380. [PMID: 25516439 DOI: 10.1161/JAHA.114.001380] [Cited by in Crossref: 89] [Cited by in F6Publishing: 40] [Article Influence: 12.7] [Reference Citation Analysis]
70 Dangas GD, Adams DH. Noncontrast Nephropathy After Percutaneous Mitral Valve Edge-to-Edge Repair. J Am Coll Cardiol 2020;76:2474-6. [PMID: 33213726 DOI: 10.1016/j.jacc.2020.10.017] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
71 Lun Z, Mai Z, Liu L, Chen G, Li H, Ying M, Wang B, Chen S, Yang Y, Liu J, Chen J, Ye J, Liu Y. Hypertension as a Risk Factor for Contrast-Associated Acute Kidney Injury: A Meta-Analysis Including 2,830,338 Patients. Kidney Blood Press Res 2021;46:670-92. [PMID: 34492656 DOI: 10.1159/000517560] [Reference Citation Analysis]
72 Longhini C, Molino C, Fabbian F. Cardiorenal syndrome: still not a defined entity. Clin Exp Nephrol 2010;14:12-21. [PMID: 20174850 DOI: 10.1007/s10157-009-0257-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
73 Gul I, Zungur M, Tastan A, Okur FF, Damar E, Uyar S, Sahin V, Tavli T. The importance of contrast volume/glomerular filtration rate ratio in contrast-induced nephropathy patients after transcatheter aortic valve implantation. Cardiorenal Med 2015;5:31-9. [PMID: 25759698 DOI: 10.1159/000369943] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
74 Goldfarb S, McCullough PA, McDermott J, Gay SB. Contrast-induced acute kidney injury: specialty-specific protocols for interventional radiology, diagnostic computed tomography radiology, and interventional cardiology. Mayo Clin Proc 2009;84:170-9. [PMID: 19181651 DOI: 10.1016/S0025-6196(11)60825-2] [Cited by in F6Publishing: 26] [Reference Citation Analysis]
75 Caiazza A, Russo L, Sabbatini M, Russo D. Hemodynamic and tubular changes induced by contrast media. Biomed Res Int 2014;2014:578974. [PMID: 24678510 DOI: 10.1155/2014/578974] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
76 Clavijo LC, Pinto TL, Kuchulakanti PK, Torguson R, Chu WW, Satler LF, Kent KM, Suddath WO, Waksman R, Pichard AD. Effect of a Rapid Intra-Arterial Infusion of Dextrose 5% Prior to Coronary Angiography on Frequency of Contrast-Induced Nephropathy in High-Risk Patients. The American Journal of Cardiology 2006;97:981-3. [DOI: 10.1016/j.amjcard.2005.10.033] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
77 Dixon SR, Grines CL, O’neill WW. The Year in Interventional Cardiology. Journal of the American College of Cardiology 2006;47:1689-706. [DOI: 10.1016/j.jacc.2006.02.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
78 Liu Y, Liu YH, Tan N, Chen JY, Zhou YL, Li LW, Duan CY, Chen PY, Luo JF, Li HL, Wei-Guo. Comparison of the efficacy of rosuvastatin versus atorvastatin in preventing contrast induced nephropathy in patient with chronic kidney disease undergoing percutaneous coronary intervention. PLoS One 2014;9:e111124. [PMID: 25357250 DOI: 10.1371/journal.pone.0111124] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
79 Yoon HJ, Hur SH. Determination of safe contrast media dosage to estimated glomerular filtration rate ratios to avoid contrast-induced nephropathy after elective percutaneous coronary intervention. Korean Circ J 2011;41:265-71. [PMID: 21731568 DOI: 10.4070/kcj.2011.41.5.265] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
80 Cho A, Lee YK, Sohn SY. Beneficial effect of statin on preventing contrast-induced acute kidney injury in patients with renal insufficiency: A meta-analysis. Medicine (Baltimore) 2020;99:e19473. [PMID: 32150109 DOI: 10.1097/MD.0000000000019473] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
81 Kandula P, Shah R, Singh N, Markwell SJ, Bhensdadia N, Navaneethan SD. Statins for prevention of contrast-induced nephropathy in patients undergoing non-emergent percutaneous coronary intervention. Nephrology (Carlton). 2010;15:165-170. [PMID: 20470274 DOI: 10.1111/j.1440-1797.2009.01204.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
82 Cely CM, Schein RM, Quartin AA. Risk of contrast induced nephropathy in the critically ill: a prospective, case matched study. Crit Care 2012;16:R67. [PMID: 22534554 DOI: 10.1186/cc11317] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.1] [Reference Citation Analysis]
83 Connolly M, McEneaney D, Menown I, Morgan N, Harbinson M. Novel Biomarkers of Acute Kidney Injury After Contrast Coronary Angiography. Cardiol Rev 2015;23:240-6. [PMID: 25699983 DOI: 10.1097/CRD.0000000000000058] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
84 Schweitzer J, Horn P, Voss F, Kivel M, Wolff G, Jung C, Zeus T, Kelm M, Westenfeld R. Incidence of Acute Kidney Injury Is Lower in High-Risk Patients Undergoing Percutaneous Coronary Intervention Supported with Impella Compared to ECMO. J Cardiovasc Transl Res 2021. [PMID: 34324156 DOI: 10.1007/s12265-021-10141-9] [Reference Citation Analysis]
85 Moulis G, Sailler L, Sommet A, Lapeyre-mestre M, Montastruc J; the French Association of Regional Pharmacovigilance Centers. Exposure to inhibitors of the renin-angiotensin system is a major independent risk factor for acute renal failure induced by sucrose-containing intravenous immunoglobulins: a case-control study: DRUGS AND IMMUNOGLOBULIN-INDUCED RENAL FAILURE. Pharmacoepidemiol Drug Saf 2012;21:314-9. [DOI: 10.1002/pds.2253] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
86 Gallegos Y, Taha AA, Rutledge DN. CE: Preventing Contrast-Induced Acute Kidney Injury. AJN, American Journal of Nursing 2016;116:38-45. [DOI: 10.1097/01.naj.0000508664.33963.20] [Reference Citation Analysis]
87 Calabrò P, Bianchi R, Crisci M, Caprile M, Bigazzi MC, Palmieri R, Golia E, De Vita A, Romano IJ, Limongelli G, Russo MG, Calabrò R. Use and efficacy of saline hydration and N-acetyl cysteine to prevent contrast-induced nephropathy in low-risk populations undergoing coronary artery angiography. Intern Emerg Med 2011;6:503-7. [DOI: 10.1007/s11739-011-0513-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
88 Ando H, Isobe S, Amano T, Yamada T, Ohtsubo H, Yuba M, Ishii H, Murohara T. Predictors of worsening renal function after computed tomography coronary angiography: Assessed by cystatin C. Journal of Cardiovascular Computed Tomography 2012;6:31-6. [DOI: 10.1016/j.jcct.2011.10.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
89 McCullough PA. Acute kidney injury with iodinated contrast. Crit Care Med 2008;36:S204-11. [PMID: 18382195 DOI: 10.1097/CCM.0b013e318168cdc3] [Cited by in Crossref: 53] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
90 Kunimura A, Ishii H, Uetani T, Harada K, Kataoka T, Takeshita M, Harada K, Okumura S, Shinoda N, Kato B, Kato M, Suzuki S, Amano T, Murohara T. Prognostic Value of Albuminuria on Cardiovascular Outcomes After Elective Percutaneous Coronary Intervention. Am J Cardiol 2016;117:714-9. [PMID: 26772442 DOI: 10.1016/j.amjcard.2015.11.054] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
91 Gül I, Cerit L, Senturk B, Zungur M, Alkan MB, Kemal H, Cerit Z, Yaman B, Usalp S, Duygu H. The Negative Effect of Mean Perfusion Pressure on the Development of Acute Kidney Injury after Transcatheter Aortic Valve Implantation. Braz J Cardiovasc Surg 2018;33:559-66. [PMID: 30652744 DOI: 10.21470/1678-9741-2018-0137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
92 Cao D, Dangas GD. Sodium Bicarbonate, Contrast-Associated Acute Kidney Injury, and Long-Term Outcomes: The End of an Era? Cardiovasc Revasc Med 2021;31:69-70. [PMID: 34364806 DOI: 10.1016/j.carrev.2021.07.019] [Reference Citation Analysis]
93 Mehran R, Owen R, Chiarito M, Baber U, Sartori S, Cao D, Nicolas J, Pivato CA, Nardin M, Krishnan P, Kini A, Sharma S, Pocock S, Dangas G. A contemporary simple risk score for prediction of contrast-associated acute kidney injury after percutaneous coronary intervention: derivation and validation from an observational registry. Lancet 2021;398:1974-83. [PMID: 34793743 DOI: 10.1016/S0140-6736(21)02326-6] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
94 Tsai TT, Patel UD, Chang TI, Kennedy KF, Masoudi FA, Matheny ME, Kosiborod M, Amin AP, Messenger JC, Rumsfeld JS, Spertus JA. Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. JACC Cardiovasc Interv 2014;7:1-9. [PMID: 24456715 DOI: 10.1016/j.jcin.2013.06.016] [Cited by in Crossref: 279] [Cited by in F6Publishing: 239] [Article Influence: 34.9] [Reference Citation Analysis]
95 Latus J, Schwenger V, Schlieper G, Reinecke H, Hoyer J, Persson PB, Remppis BA, Mahfoud F. [Contrast medium-induced acute kidney injury-Consensus paper of the working group "Heart and Kidney" of the German Cardiac Society and the German Society of Nephrology]. Internist (Berl) 2021;62:111-20. [PMID: 33349899 DOI: 10.1007/s00108-020-00938-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
96 Norgaz T, Gorgulu S, Dagdelen S. Arterial anatomic variations and its influence on transradial coronary procedural outcome. J Interv Cardiol 2012;25:418-24. [PMID: 22860990 DOI: 10.1111/j.1540-8183.2012.00693.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
97 Peiyuan H, Jingang Y, Haiyan X, Xiaojin G, Ying X, Yuan W, Wei L, Yang W, Xinran T, Ruohua Y, Chen J, Lei S, Xuan Z, Rui F, Yunqing Y, Qiuting D, Hui S, Xinxin Y, Runlin G, Yuejin Y; CAMI Registry study group. The Comparison of the Outcomes between Primary PCI, Fibrinolysis, and No Reperfusion in Patients ≥ 75 Years Old with ST-Segment Elevation Myocardial Infarction: Results from the Chinese Acute Myocardial Infarction (CAMI) Registry. PLoS One 2016;11:e0165672. [PMID: 27812152 DOI: 10.1371/journal.pone.0165672] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
98 Bağcı A, Aksoy F, Baş HA. Akut koroner sendromda kontrast nefropati gelişimi ile Syntax Skoru arasındaki ilişki. Cukurova Medical Journal 2019;44:1181-8. [DOI: 10.17826/cumj.512112] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
99 Li X, Li T, Cong H. Is angiotensin-converting enzyme inhibitor a contraindication for contrast-induced nephropathy prophylaxis? A review about its paradox. Cardiovasc Ther 2012;30:273-6. [PMID: 21884031 DOI: 10.1111/j.1755-5922.2011.00299.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
100 Sendeski MM, Persson AB, Liu ZZ, Busch JF, Weikert S, Persson PB, Hippenstiel S, Patzak A. Iodinated contrast media cause endothelial damage leading to vasoconstriction of human and rat vasa recta. Am J Physiol Renal Physiol 2012;303:F1592-8. [PMID: 23077094 DOI: 10.1152/ajprenal.00471.2012] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 3.9] [Reference Citation Analysis]
101 Bhandari P, Shah Z, Patel K, Patel R. Contrast-induced acute kidney injury following coronary angiography in patients with end-stage liver disease. J Community Hosp Intern Med Perspect 2019;9:403-9. [PMID: 31723384 DOI: 10.1080/20009666.2019.1661148] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
102 Kroll RG, Yelavarthy P, Menees DS, Sutton NR. Predicting Contrast-Induced Renal Complications. Interv Cardiol Clin 2020;9:321-33. [PMID: 32471673 DOI: 10.1016/j.iccl.2020.02.003] [Reference Citation Analysis]
103 Ng AK, Ng PY, Ip A, Lam L, Ling IW, Wong AS, Yap DY, Siu C. Impact of contrast-induced acute kidney injury on long-term major adverse cardiovascular events and kidney function after percutaneous coronary intervention: insights from a territory-wide cohort study in Hong Kong. Clinical Kidney Journal 2021. [DOI: 10.1093/ckj/sfab212] [Reference Citation Analysis]
104 Ding FH, Lu L, Zhang RY, Zhu TQ, Pu LJ, Zhang Q, Chen QJ, Hu J, Yang ZK, Shen WF. Impact of elevated serum glycated albumin levels on contrast-induced acute kidney injury in diabetic patients with moderate to severe renal insufficiency undergoing coronary angiography. Int J Cardiol 2013;167:369-73. [PMID: 22244477 DOI: 10.1016/j.ijcard.2011.12.101] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
105 Shinoura S, Tokushige A, Chinen K, Mori H, Kato S, Ueda S. Association between contrast-induced nephrotoxicity and contrast enhanced computed tomography followed by endoscopic retrograde cholangiopancreatography. Eur J Radiol 2020;129:109074. [PMID: 32473539 DOI: 10.1016/j.ejrad.2020.109074] [Reference Citation Analysis]
106 Bangalore S, Barsness GW, Dangas GD, Kern MJ, Rao SV, Shore-Lesserson L, Tamis-Holland JE. Evidence-Based Practices in the Cardiac Catheterization Laboratory: A Scientific Statement From the American Heart Association. Circulation 2021;144:e107-19. [PMID: 34187171 DOI: 10.1161/CIR.0000000000000996] [Reference Citation Analysis]
107 Solomon R, Barrett B. Follow-up of patients with contrast-induced nephropathy. Kidney International 2006;69:S46-50. [DOI: 10.1038/sj.ki.5000374] [Cited by in Crossref: 45] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
108 Ma H, Liu Y, Xie H, Zhang G, Zhan H, Liu Z, Wang P, Geng Q, Guo L. The renoprotective effects of simvastatin and atorvastatin in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational study. Medicine (Baltimore) 2017;96:e7351. [PMID: 28796030 DOI: 10.1097/MD.0000000000007351] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
109 Isobe S, Yamada T, Yuba M, Hayashi M, Ishii H, Murohara T. Relationship between pre-procedural microalbuminuria and renal functional changes after coronary computed tomography in diabetic patients. J Cardiol 2017;69:666-70. [PMID: 27424108 DOI: 10.1016/j.jjcc.2016.06.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
110 Kumar D, Liaquat H, Sial JA, Saghir T, Kumari R, Kumar H, Karim M, Rai K, Bai R. Risk Factors Associated With Contrast-Induced Nephropathy after Primary Percutaneous Coronary Intervention. Cureus 2020;12:e9721. [PMID: 32944440 DOI: 10.7759/cureus.9721] [Reference Citation Analysis]
111 Guastoni C, De Servi S, Dʼamico M. The role of dialysis in contrast-induced nephropathy: doubts and certainties: . Journal of Cardiovascular Medicine 2007;8:549-57. [DOI: 10.2459/01.jcm.0000281709.43681.a5] [Cited by in Crossref: 5] [Article Influence: 0.3] [Reference Citation Analysis]
112 Ko YG, Lee BK, Kang WC, Moon JY, Cho YH, Choi SH, Hong MK, Jang Y, Kim JY, Min PK, Kwon HM; PRINCIPLE Investigators. Preventive effect of pretreatment with intravenous nicorandil on contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography (PRINCIPLE Study). Yonsei Med J 2013;54:957-64. [PMID: 23709432 DOI: 10.3349/ymj.2013.54.4.957] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
113 Li H, Wang C, Liu C, Li R, Zou M, Cheng G. Efficacy of Short-Term Statin Treatment for the Prevention of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography/Percutaneous Coronary Intervention: A Meta-Analysis of 21 Randomized Controlled Trials. Am J Cardiovasc Drugs 2016;16:201-19. [PMID: 26899537 DOI: 10.1007/s40256-016-0164-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 6.6] [Reference Citation Analysis]
114 Alharazy SM, Kong N, Saidin R, Gafor AHA, Maskon O, Mohd M, Zakaria SZS. Neutrophil Gelatinase-Associated Lipocalin as an Early Marker of Contrast-Induced Nephropathy After Coronary Angiography. Angiology 2014;65:216-23. [DOI: 10.1177/0003319712474947] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
115 Allali A, Traboulsi H, Sulimov DS, Abdel-Wahab M, Woitek F, Mangner N, Hemetsberger R, Mankerious N, Elbasha K, Toelg R, Richardt G. Feasibility and safety of minimal-contrast IVUS-guided rotational atherectomy for complex calcified coronary artery disease. Clin Res Cardiol 2021. [PMID: 34255133 DOI: 10.1007/s00392-021-01906-y] [Reference Citation Analysis]
116 Hashimoto S, Shiraishi J, Nakamura T, Nishikawa M, Yanagiuchi T, Ito D, Kimura M, Kishita E, Nakagawa Y, Hyogo M, Shima T, Sawada T, Matoba S, Yamada H, Matsumuro A, Shirayama T, Kitamura M, Kohno Y, Furukawa K. Survivors of acute myocardial infarction at left main trunk undergoing primary percutaneous coronary intervention. Cardiovasc Interv and Ther 2016;31:89-95. [DOI: 10.1007/s12928-015-0352-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
117 Chawla R, Turlington J, Arora P, Jovin IS. Race and contrast-induced nephropathy in patients undergoing coronary angiography and cardiac catheterization. Int J Cardiol 2017;230:610-3. [PMID: 28040287 DOI: 10.1016/j.ijcard.2016.12.046] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
118 Zungur M, Gul I, Tastan A, Damar E, Tavli T. Predictive Value of the Mehran Score for Contrast-Induced Nephropathy after Transcatheter Aortic Valve Implantation in Patients with Aortic Stenosis. Cardiorenal Med 2016;6:279-88. [PMID: 27648009 DOI: 10.1159/000443936] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
119 Liu YH, Liu Y, Tan N, Chen JY, Zhou YL, Luo JF, Yu DQ, Li LW, Li HL, Ye P, Ran P. Contrast-induced nephropathy following chronic total occlusion percutaneous coronary intervention in patients with chronic kidney disease. Eur Radiol 2015;25:2274-81. [PMID: 25981215 DOI: 10.1007/s00330-014-3360-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
120 McCullough PA, Adam A, Becker CR, Davidson C, Lameire N, Stacul F, Tumlin J; CIN Consensus Working Panel. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol 2006;98:5K-13K. [PMID: 16949375 DOI: 10.1016/j.amjcard.2006.01.019] [Cited by in Crossref: 272] [Cited by in F6Publishing: 219] [Article Influence: 17.0] [Reference Citation Analysis]
121 Dugbartey GJ, Redington AN. Prevention of contrast-induced nephropathy by limb ischemic preconditioning: underlying mechanisms and clinical effects. American Journal of Physiology-Renal Physiology 2018;314:F319-28. [DOI: 10.1152/ajprenal.00130.2017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
122 McDonald JS, Leake CB, McDonald RJ, Gulati R, Katzberg RW, Williamson EE, Kallmes DF. Acute Kidney Injury After Intravenous Versus Intra-Arterial Contrast Material Administration in a Paired Cohort. Invest Radiol 2016;51:804-9. [PMID: 27299579 DOI: 10.1097/RLI.0000000000000298] [Cited by in Crossref: 34] [Cited by in F6Publishing: 12] [Article Influence: 6.8] [Reference Citation Analysis]
123 Kiski D, Stepper W, Breithardt G, Reinecke H. Impact of female gender on frequency of contrast medium-induced nephropathy: post hoc analysis of dialysis versus diuresis trial. J Womens Health (Larchmt) 2010;19:1363-8. [PMID: 20545479 DOI: 10.1089/jwh.2009.1821] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
124 Cho A, Lee JE, Yoon JY, Jang HR, Huh W, Kim Y, Kim DJ, Oh HY. Effect of an Electronic Alert on Risk of Contrast-Induced Acute Kidney Injury in Hospitalized Patients Undergoing Computed Tomography. American Journal of Kidney Diseases 2012;60:74-81. [DOI: 10.1053/j.ajkd.2012.02.331] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
125 Chang CF, Liu XM, Peyton KJ, Durante W. Heme oxygenase-1 counteracts contrast media-induced endothelial cell dysfunction. Biochem Pharmacol 2014;87:303-11. [PMID: 24239896 DOI: 10.1016/j.bcp.2013.11.002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
126 Chalikias G, Drosos I, Tziakas DN. Contrast-Induced Acute Kidney Injury: An Update. Cardiovasc Drugs Ther 2016;30:215-28. [PMID: 26780748 DOI: 10.1007/s10557-015-6635-0] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
127 Nayak KR, Mehta HS, Price MJ, Russo RJ, Stinis CT, Moses JW, Mehran R, Leon MB, Kandzari DE, Teirstein PS. A novel technique for ultra-low contrast administration during angiography or intervention. Catheter Cardiovasc Interv 2010;75:1076-83. [PMID: 20146209 DOI: 10.1002/ccd.22414] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
128 Kalyesubula R, Bagasha P, Perazella MA. ACE-I/ARB therapy prior to contrast exposure: what should the clinician do? Biomed Res Int 2014;2014:423848. [PMID: 24605330 DOI: 10.1155/2014/423848] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
129 Nomura S, Taki F, Tamagaki K, Futatsuyama M, Nishihara S, Anzai H, Nishi Y, Takao N, Hayashida N, Komatsu Y. Renal outcome of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease. International Journal of Cardiology 2011;146:295-6. [DOI: 10.1016/j.ijcard.2010.10.090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
130 Ferrario F, Barone MT, Landoni G, Genderini A, Heidemperger M, Trezzi M, Piccaluga E, Danna P, Scorza D. Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy--a randomized controlled study. Nephrol Dial Transplant 2009;24:3103-7. [PMID: 19549691 DOI: 10.1093/ndt/gfp306] [Cited by in Crossref: 38] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
131 Lei L, Xue Y, Guo Z, Liu B, He Y, Song F, Liu J, Sun G, Chen L, Chen K, Huang Z, Ying M, Zhang L, Su Z, Pan L, Chen S, Chen J, Liu Y. A comparison between different definitions of contrast-induced acute kidney injury for long-term mortality in patients with acute myocardial infarction. Int J Cardiol Heart Vasc 2020;28:100522. [PMID: 32382653 DOI: 10.1016/j.ijcha.2020.100522] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
132 Sambol EB, Van der Meer JG, Graham A, Goldstein LJ, Karwowski JK, Dayal R, Derubertis B, Kent KC. The use of gadolinium for arterial interventions. Ann Vasc Surg 2011;25:366-76. [PMID: 21288688 DOI: 10.1016/j.avsg.2010.09.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
133 Lei L, He Y, Guo Z, Liu B, Liu J, Nie Z, Chen G, Liu L, Lin M, Yan W, Chen S, Jiyan C, Liu Y. A Simple Nomogram to Predict Contrast-Induced Acute Kidney Injury in Patients with Congestive Heart Failure Undergoing Coronary Angiography. Cardiol Res Pract 2021;2021:9614953. [PMID: 33859840 DOI: 10.1155/2021/9614953] [Reference Citation Analysis]
134 Connolly M, Kinnin M, McEneaney D, Menown I, Kurth M, Lamont J, Morgan N, Harbinson M. Prediction of contrast induced acute kidney injury using novel biomarkers following contrast coronary angiography. QJM 2018;111:103-10. [PMID: 29069419 DOI: 10.1093/qjmed/hcx201] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
135 Liu Y, Liu Y, Chen J, Tan N, Li H, Luo J, Chen Z, Yu D, Li G, Huang W, Xie N, He P, Yang J, Duan C, Chen S, Chen P. Renal function-adjusted safe contrast volume to prevent contrast-induced nephropathy and poor long-term outcomes in patients with chronic total occlusions undergoing cardiac catheterization. European Heart Journal Supplements 2015;17:C17-25. [DOI: 10.1093/eurheartj/suv027] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
136 Yun KH, Lim JH, Hwang KB, Woo SH, Jeong JW, Kim YC, Joe DY, Ko JS, Rhee SJ, Lee EM, Oh SK. Effect of High Dose Rosuvastatin Loading before Percutaneous Coronary Intervention on Contrast-Induced Nephropathy. Korean Circ J 2014;44:301-6. [PMID: 25278982 DOI: 10.4070/kcj.2014.44.5.301] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
137 Kurogi K, Ishii M, Sakamoto K, Komaki S, Marume K, Kusaka H, Yamamoto N, Arima Y, Yamamoto E, Kaikita K, Tsujita K. Persistent Renal Dysfunction in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction. J Am Heart Assoc 2019;8:e014096. [PMID: 31766973 DOI: 10.1161/JAHA.119.014096] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
138 Heringlake M, Kindgen-milles D, Hackmann F, Haake N, Kielstein J, Lance M, Lufft H, Just S, Trabold B, Scherlitz A, Schirmer U, Schmitt D, Vargas-hein O, Markewitz A. Pathophysiologie, Prophylaxe und Therapie von Herzchirurgie-assoziierten Nierenfunktionsstörungen: Eine Stellungnahme der Arbeitsgruppe Niere des gemeinschaftlichen Arbeitskreises Intensivmedizin von DGAI und DGTHG unter Berücksichtigung der Konsensus-Empfehlungen der Acute Dialysis Quality Initiative. Z Herz- Thorax- Gefäßchir 2009;23:349-73. [DOI: 10.1007/s00398-009-0743-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
139 Brown JR, Malenka DJ, DeVries JT, Robb JF, Jayne JE, Friedman BJ, Hettleman BD, Niles NW, Kaplan AV, Schoolwerth AC, Thompson CA. Transient and persistent renal dysfunction are predictors of survival after percutaneous coronary intervention: insights from the Dartmouth Dynamic Registry. Catheter Cardiovasc Interv 2008;72:347-54. [PMID: 18729173 DOI: 10.1002/ccd.21619] [Cited by in Crossref: 78] [Cited by in F6Publishing: 67] [Article Influence: 5.6] [Reference Citation Analysis]
140 Nunag M, Brogan M, Garrick R. Mitigating contrast-induced acute kidney injury associated with cardiac catheterization. Cardiol Rev. 2009;17:263-269. [PMID: 19829174 DOI: 10.1097/crd.0b013e3181bc359d] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
141 Saratzis A, Shakespeare J, Jones O, Bown M, Mahmood A, Imray C. Pre-operative Functional Cardiovascular Reserve Is Associated with Acute Kidney Injury after Intervention. European Journal of Vascular and Endovascular Surgery 2017;53:717-24. [DOI: 10.1016/j.ejvs.2017.01.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
142 Heitmeyer C, Hölscher B, Fobker M, Breithardt G, Hausberg M, Reinecke H. Prognostic value of different laboratory measures of renal function for long-term mortality after contrast media-associated renal impairment. Clin Cardiol 2010;33:E51-9. [PMID: 21184545 DOI: 10.1002/clc.20323] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
143 Chung W, Kim AJ, Ro H, Chang JH, Lee HH, Jung JY. Hyperuricemia Is an Independent Risk Factor for Mortality Only if Chronic Kidney Disease Is Present. Am J Nephrol 2013;37:452-61. [DOI: 10.1159/000350534] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
144 Chandrasekaran U, Burkhoff D, Ishikawa K, Swain L, Sunagawa K, Møller J, Santos-Gallego C, Annamalai S, Udelson J, Westenfeld R, Kapur N, Qiao X, Wiora J, Schäfer A, Bernhardt A, Kochar A, Kloner R, Faraz H. Proceedings of the 3rd annual Acute Cardiac Unloading and REcovery (A-CURE) symposium. BMC Cardiovasc Disord 2019;19:27. [PMID: 30732562 DOI: 10.1186/s12872-019-1000-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
145 Saltzman HE, Sharma K, Mather PJ, Rubin S, Adams S, Whellan DJ. Renal dysfunction in heart failure patients: what is the evidence? Heart Fail Rev 2007;12:37-47. [PMID: 17393304 DOI: 10.1007/s10741-007-9006-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
146 Evola S, Lunetta M, Macaione F, Fonte G, Milana G, Corrado E, Bonura F, Novo G, Hoffmann E, Novo S. Risk factors for contrast induced nephropathy: a study among Italian patients. Indian Heart J 2012;64:484-91. [PMID: 23102387 DOI: 10.1016/j.ihj.2012.07.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
147 La Manna G, Pancaldi LG, Capecchi A, Maska E, Comai G, Cappuccilli ML, Carretta E, Lombardi A, Colì L, Stefoni S. Risk for contrast nephropathy in patients undergoing coronarography. Artif Organs 2010;34:E193-9. [PMID: 20482707 DOI: 10.1111/j.1525-1594.2009.00984.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
148 Solomon RJ, Mehran R, Natarajan MK, Doucet S, Katholi RE, Staniloae CS, Sharma SK, Labinaz M, Gelormini JL, Barrett BJ. Contrast-induced nephropathy and long-term adverse events: cause and effect? Clin J Am Soc Nephrol. 2009;4:1162-1169. [PMID: 19556381 DOI: 10.2215/cjn.00550109] [Cited by in Crossref: 186] [Cited by in F6Publishing: 57] [Article Influence: 14.3] [Reference Citation Analysis]
149 Jarai R, Dangas G, Huber K, Xu K, Brodie BR, Witzenbichler B, Metzger DC, Radke PW, Yu J, Claessen BE, Genereux P, Mehran R, Stone GW. B-type Natriuretic Peptide and Risk of Contrast-Induced Acute Kidney Injury in Acute ST-Segment–Elevation Myocardial Infarction: A Substudy from the HORIZONS-AMI Trial. Circ Cardiovasc Interv 2012;5:813-20. [DOI: 10.1161/circinterventions.112.972356] [Cited by in Crossref: 28] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
150 Oduncu V, Erkol A, Karabay CY, Şengül C, Tanalp AC, Fotbolcu H, Özveren O, Bitigen A, Pala S, Kırma C. Relation of the severity of contrast induced nephropathy to SYNTAX score and long term prognosis in patients treated with primary percutaneous coronary intervention. Int J Cardiol 2013;168:3480-5. [PMID: 23688433 DOI: 10.1016/j.ijcard.2013.04.166] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
151 Kim SM, Cha R, Lee JP, Kim DK, Oh K, Joo KW, Lim CS, Kim S, Kim YS. Incidence and Outcomes of Contrast-Induced Nephropathy After Computed Tomography in Patients With CKD: A Quality Improvement Report. American Journal of Kidney Diseases 2010;55:1018-25. [DOI: 10.1053/j.ajkd.2009.10.057] [Cited by in Crossref: 65] [Cited by in F6Publishing: 54] [Article Influence: 5.4] [Reference Citation Analysis]
152 Vuurmans T, Er L, Sirker A, Djurdjev O, Simkus G, Levin A. Long-term patient and kidney survival after coronary artery bypass grafting, percutaneous coronary intervention, or medical therapy for patients with chronic kidney disease: a propensity-matched cohort study. Coronary Artery Disease 2018;29:8-16. [DOI: 10.1097/mca.0000000000000557] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
153 Huang SS, Huang PH, Leu HB, Wu TC, Chen JW, Lin SJ. Significance of serum FGF-23 for risk assessment of contrast-associated acute kidney injury and clinical outcomes in patients undergoing coronary angiography. PLoS One 2021;16:e0254835. [PMID: 34297744 DOI: 10.1371/journal.pone.0254835] [Reference Citation Analysis]
154 Itoh Y, Yano T, Sendo T, Sueyasu M, Hirano K, Kanaide H, Oishi R. Involvement of de novo ceramide synthesis in radiocontrast-induced renal tubular cell injury. Kidney Int. 2006;69:288-297. [PMID: 16408118 DOI: 10.1038/sj.ki.5000057] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
155 Stacul F, van der Molen AJ, Reimer P, Webb JA, Thomsen HS, Morcos SK, Almén T, Aspelin P, Bellin MF, Clement O. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol. 2011;21:2527-2541. [PMID: 21866433 DOI: 10.1007/s00330-011-2225-0] [Cited by in Crossref: 538] [Cited by in F6Publishing: 456] [Article Influence: 48.9] [Reference Citation Analysis]
156 Chen SQ, Liu Y, Smyth B, Li HL, Sun GL, Chen ZJ, Zhou YL. Clinical Implications of Contrast-Induced Nephropathy in Patients Without Baseline Renal Dysfunction Undergoing Coronary Angiography. Heart Lung Circ 2019;28:866-73. [PMID: 29960836 DOI: 10.1016/j.hlc.2018.04.291] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
157 Meyer M, Dauerman HL, Bell SP, Lewinter MM, Lustgarten DL. Coronary venous capture of contrast during angiography. J Interv Cardiol 2006;19:401-4. [PMID: 17020564 DOI: 10.1111/j.1540-8183.2006.00193.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
158 Han XF, Zhang XX, Liu KM, Tan H, Zhang Q. Contrast-induced nephropathy in patients with diabetes mellitus between iso- and low-osmolar contrast media: A meta-analysis of full-text prospective, randomized controlled trials. PLoS One 2018;13:e0194330. [PMID: 29558481 DOI: 10.1371/journal.pone.0194330] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
159 Kurogi K, Ishii M, Sakamoto K, Kusaka H, Yamamoto N, Takashio S, Arima Y, Yamamoto E, Kaikita K, Tsujita K. Minimum-Contrast Percutaneous Coronary Intervention Guided by Optical Coherence Tomography Using Low-Molecular Weight Dextran. JACC Cardiovasc Interv 2020;13:1270-2. [PMID: 32438999 DOI: 10.1016/j.jcin.2020.01.205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
160 Liu T, Lee SR. Poor Prognosis of Contrast-Induced Nephropathy during Long Term Follow Up. Chonnam Med J 2021;57:197-203. [PMID: 34621640 DOI: 10.4068/cmj.2021.57.3.197] [Reference Citation Analysis]
161 Hernando L, Canovas E, Freites A, de La Rosa A, Alonso J, del Castillo R, Salinas P, Montalvo GB, Huelmos AI, Botas J. Prevalencia y pronóstico de la nefropatía tras intervencionismo coronario percutáneo de pacientes con síndrome coronario agudo y función renal normal. Revista Española de Cardiología 2015;68:310-6. [DOI: 10.1016/j.recesp.2014.04.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
162 Premawardhana D, Sekar B, Ul-Haq MZ, Sheikh A, Gallagher S, Anderson R, Copt S, Ossei-Gerning N, Kinnaird T. Routine iso-osmolar contrast media use and acute kidney injury following percutaneous coronary intervention for ST elevation myocardial infarction. Minerva Cardioangiol 2019;67:380-91. [PMID: 31527583 DOI: 10.23736/S0026-4725.19.04925-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
163 Alpert MA, Carlino C. Pre-procedural blood glucose levels: a new risk marker for contrast-induced acute kidney injury in patients without diabetes with acute myocardial infarction. J Am Coll Cardiol 2010;55:1441-3. [PMID: 20359593 DOI: 10.1016/j.jacc.2009.10.066] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
164 Toprak O. Conflicting and new risk factors for contrast induced nephropathy. J Urol 2007;178:2277-83. [PMID: 17936812 DOI: 10.1016/j.juro.2007.08.054] [Cited by in Crossref: 59] [Cited by in F6Publishing: 40] [Article Influence: 3.9] [Reference Citation Analysis]
165 Blankenship JC, Moussa ID, Chambers CC, Brilakis ES, Haldis TA, Morrison DA, Dehmer GJ. Staging of multivessel percutaneous coronary interventions: An expert consensus statement from the Society for Cardiovascular Angiography and Interventions. Cathet Cardiovasc Intervent 2012;79:1138-52. [DOI: 10.1002/ccd.23353] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
166 Victor SM, Gnanaraj A, S V, Deshmukh R, Kandasamy M, Janakiraman E, Pandurangi UM, Latchumanadhas K, Abraham G, Mullasari AS. Risk scoring system to predict contrast induced nephropathy following percutaneous coronary intervention. Indian Heart J 2014;66:517-24. [PMID: 25443605 DOI: 10.1016/j.ihj.2014.05.025] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
167 Singh M, Karakala N, Shah SV. Long-term Adverse Events Associated With Acute Kidney Injury. Journal of Renal Nutrition 2017;27:462-4. [DOI: 10.1053/j.jrn.2017.05.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
168 Liu ZZ, Schmerbach K, Lu Y, Perlewitz A, Nikitina T, Cantow K, Seeliger E, Persson PB, Patzak A, Liu R. Iodinated contrast media cause direct tubular cell damage, leading to oxidative stress, low nitric oxide, and impairment of tubuloglomerular feedback. Am J Physiol Renal Physiol. 2014;306:F864-F872. [PMID: 24431205 DOI: 10.1152/ajprenal.00302.2013] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 4.8] [Reference Citation Analysis]
169 Ribichini F, Gambaro G, Graziani MS, Pighi M, Pesarini G, Pasoli P, Anselmi M, Ferrero V, Yabarek T, Sorio A, Rizzotti P, Lupo A, Vassanelli C. Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. Clin Chem 2012;58:458-64. [PMID: 22166252 DOI: 10.1373/clinchem.2011.170464] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.9] [Reference Citation Analysis]
170 Toprak O, Cirit M. Risk Factors and Therapy Strategies for Contrast-Induced Nephropathy. Renal Failure 2009;28:365-81. [DOI: 10.1080/08860220600683524] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
171 Burchardt P, Guzik P, Tabaczewski P, Synowiec T, Bogdan M, Faner P, Chmielarz-Sobocińska A, Palasz A. Early renal dysfunction after contrast media administration despite prophylactic hydration. Int J Cardiovasc Imaging 2013;29:959-66. [PMID: 23378157 DOI: 10.1007/s10554-013-0186-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
172 Reuter SB, Harutyunyan M, Mygind ND, Jørgensen E, Kastrup J. The influence of contrast media on kidney function in patients with stable coronary artery disease. Scand Cardiovasc J 2014;48:234-40. [PMID: 24941300 DOI: 10.3109/14017431.2014.934713] [Reference Citation Analysis]
173 Wu Z, Zhang H, Jin W, Liu Y, Lu L, Chen Q, Zhang R. The Effect of Renin-Angiotensin-Aldosterone System Blockade Medications on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Meta-Analysis. PLoS One 2015;10:e0129747. [PMID: 26083525 DOI: 10.1371/journal.pone.0129747] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
174 Akin F, Celik O, Altun I, Ayca B, Ozturk D, Satilmis S, Ayaz A, Tasbulak O. Relation of red cell distribution width to contrast-induced acute kidney injury in patients undergoing a primary percutaneous coronary intervention. Coron Artery Dis 2015;26:289-95. [PMID: 25714066 DOI: 10.1097/MCA.0000000000000223] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
175 Obata Y, Kamijo-Ikemori A, Ichikawa D, Sugaya T, Kimura K, Shibagaki Y, Tateda T. Clinical usefulness of urinary liver-type fatty-acid-binding protein as a perioperative marker of acute kidney injury in patients undergoing endovascular or open-abdominal aortic aneurysm repair. J Anesth 2016;30:89-99. [PMID: 26585768 DOI: 10.1007/s00540-015-2095-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
176 Wang Y, Shi Y, Xu X, Ge W, Yang S, Lu C. Effects of probucol on contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention. Medicine (Baltimore) 2019;98:e16049. [PMID: 31232940 DOI: 10.1097/MD.0000000000016049] [Reference Citation Analysis]
177 Barbieri L, Verdoia M, Nardin M, Marino P, Suryapranata H, De Luca G; Novara Atherosclerosis Study Group (NAS). Gender Difference in the Risk of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention. Angiology 2017;68:542-6. [PMID: 27662891 DOI: 10.1177/0003319716669429] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
178 Limbruno U, Picchi A, Micheli A, Calabria P, Cortese B, Brizi G, Severi S, De Caterina R. Refining the assessment of contrast-induced acute kidney injury: the load-to-damage relationship. Journal of Cardiovascular Medicine 2014;15:587-94. [DOI: 10.2459/jcm.0b013e3283638e56] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
179 Abe M, Morimoto T, Akao M, Furukawa Y, Nakagawa Y, Shizuta S, Ehara N, Taniguchi R, Doi T, Nishiyama K, Ozasa N, Saito N, Hoshino K, Mitsuoka H, Toma M, Tamura T, Haruna Y, Kita T, Kimura T. Relation of contrast-induced nephropathy to long-term mortality after percutaneous coronary intervention. Am J Cardiol 2014;114:362-8. [PMID: 24927973 DOI: 10.1016/j.amjcard.2014.05.009] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 7.3] [Reference Citation Analysis]
180 Evseeva MV, Karetnikova VN, Barbarash OL. [Renal dysfunction in patients with myocardial infarction concurrent with type 2 diabetes mellitus]. Ter Arkh 2015;87:105-8. [PMID: 25823278 DOI: 10.17116/terarkh2015871105-108] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
181 Rudnick M, Feldman H. Contrast-induced nephropathy: what are the true clinical consequences? Clin J Am Soc Nephrol. 2008;3:263-272. [PMID: 18178787 DOI: 10.2215/cjn.03690907] [Cited by in Crossref: 97] [Cited by in F6Publishing: 25] [Article Influence: 6.9] [Reference Citation Analysis]
182 Aggarwal D, Gurm HS. A Practical Approach to Preventing Renal Complications in the Catheterization Laboratory. Interv Cardiol Clin 2020;9:403-7. [PMID: 32471680 DOI: 10.1016/j.iccl.2020.02.011] [Reference Citation Analysis]
183 Martin DR, Semelka RC, Chapman A, Peters H, Finn PJ, Kalb B, Thomsen H. Nephrogenic systemic fibrosis versus contrast-induced nephropathy: Risks and benefits of contrast-enhanced MR and CT in renally impaired patients. J Magn Reson Imaging 2009;30:1350-6. [DOI: 10.1002/jmri.21968] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
184 Barbieri L, Verdoia M, Marino P, Suryapranata H, De Luca G; Novara Atherosclerosis Study Group. Contrast volume to creatinine clearance ratio for the prediction of contrast-induced nephropathy in patients undergoing coronary angiography or percutaneous intervention. Eur J Prev Cardiol. 2016;23:931-937. [PMID: 26525064 DOI: 10.1177/2047487315614493] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
185 Yoshikawa D, Isobe S, Sato K, Ohashi T, Fujiwara Y, Ohyama H, Ishii H, Murohara T. Importance of oral fluid intake after coronary computed tomography angiography: an observational study. Eur J Radiol 2011;77:118-22. [PMID: 19695806 DOI: 10.1016/j.ejrad.2009.07.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
186 Lepanto L, Tang A, Murphy-lavallée J, Billiard J. The Canadian Association of Radiologists Guidelines for the Prevention of Contrast-induced Nephropathy: A Critical Appraisal. Can Assoc Radiol J 2011;62:238-42. [DOI: 10.1016/j.carj.2010.07.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
187 Jens S, Schreuder SM, De Boo DW, van Dijk LC, van Overhagen H, Bipat S, Koelemay MJ, Reekers JA. Lowering iodinated contrast concentration in infrainguinal endovascular interventions: a three-armed randomized controlled non-inferiority trial. Eur Radiol 2016;26:2446-54. [PMID: 26630997 DOI: 10.1007/s00330-015-4109-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
188 Patel K, King CA, Jovin IS. Angiotensin-converting enzyme inhibitors and their effects on contrast-induced nephropathy after cardiac catheterization or percutaneous coronary intervention. Cardiovascular Revascularization Medicine 2011;12:90-3. [DOI: 10.1016/j.carrev.2010.01.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
189 Turan B, Erkol A, Gül M, Fındıkçıoğlu U, Erden İ. Effect of Contrast-Induced Nephropathy on the Long-Term Outcome of Patients with Non-ST Segment Elevation Myocardial Infarction. Cardiorenal Med 2015;5:116-24. [PMID: 25999960 DOI: 10.1159/000371900] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
190 Rahim HM, Flattery E, Gkargkoulas F, Maehara A, Mintz GS, Hardy MA, Cohen DJ, Dube GK, Crew RJ, Mohan S, Radhakrishnan J, Ratner LE, Moses JW, Ben-Yehuda O, Kirtane AJ, Stone GW, Leon MB, Karmpaliotis D, Ali ZA. Ultra-low-contrast angiography in patients with advanced chronic kidney disease and previous coronary artery bypass surgery. Coron Artery Dis 2019;30:346-51. [PMID: 31094895 DOI: 10.1097/MCA.0000000000000741] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
191 Traub SJ, Mitchell AM, Jones AE, Tang A, O'Connor J, Nelson T, Kellum J, Shapiro NI. N-acetylcysteine plus intravenous fluids versus intravenous fluids alone to prevent contrast-induced nephropathy in emergency computed tomography. Ann Emerg Med 2013;62:511-520.e25. [PMID: 23769807 DOI: 10.1016/j.annemergmed.2013.04.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
192 Crimi G, Leonardi S, Costa F, Ariotti S, Tebaldi M, Biscaglia S, Valgimigli M. Incidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. insights from the all-comer PRODIGY trial. Catheter Cardiovasc Interv 2015;86:E19-27. [PMID: 25703119 DOI: 10.1002/ccd.25822] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
193 Kurtul A, Yarlioglues M, Duran M. Predictive Value of CHA2DS2-VASC Score for Contrast-Induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome. The American Journal of Cardiology 2017;119:819-25. [DOI: 10.1016/j.amjcard.2016.11.033] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
194 Rear R, Bell RM, Hausenloy DJ. Contrast-induced nephropathy following angiography and cardiac interventions. Heart. 2016;102:638-648. [PMID: 26857214 DOI: 10.1136/heartjnl-2014-306962] [Cited by in Crossref: 82] [Cited by in F6Publishing: 70] [Article Influence: 13.7] [Reference Citation Analysis]
195 Nough H, Eghbal F, Soltani M, Nejafi F, Falahzadeh H, Fazel H, Sheikhvatan M. Incidence and Main Determinants of Contrast-Induced Nephropathy following Coronary Angiography or Subsequent Balloon Angioplasty. Cardiorenal Med 2013;3:128-35. [PMID: 23922553 DOI: 10.1159/000351981] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
196 Ibrahim TA, El-mawardy RH, El-serafy AS, El-fekky EM. Trimetazidine in the prevention of contrast-induced nephropathy in chronic kidney disease. Cardiovascular Revascularization Medicine 2017;18:315-9. [DOI: 10.1016/j.carrev.2017.02.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
197 Hörl WH. [Contrast induced nephropathy]. Wien Klin Wochenschr 2009;121:15-32. [PMID: 19263010 DOI: 10.1007/s00508-009-1145-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
198 Bouzas-Mosquera A, Vázquez-Rodríguez JM, Calviño-Santos R, Peteiro-Vázquez J, Flores-Ríos X, Marzoa-Rivas R, Piñón-Esteban P, Aldama-López G, Salgado-Fernández J, Vázquez-González N, Castro-Beiras A. [Contrast-induced nephropathy and acute renal failure following emergent cardiac catheterization: incidence, risk factors and prognosis]. Rev Esp Cardiol 2007;60:1026-34. [PMID: 17953923 DOI: 10.1157/13111234] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
199 Harjai KJ, Raizada A, Shenoy C, Sattur S, Orshaw P, Yaeger K, Boura J, Aboufares A, Sporn D, Stapleton D. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system. Am J Cardiol 2008;101:812-9. [PMID: 18328846 DOI: 10.1016/j.amjcard.2007.10.051] [Cited by in Crossref: 126] [Cited by in F6Publishing: 110] [Article Influence: 9.0] [Reference Citation Analysis]
200 Mohammed NM, Mahfouz A, Achkar K, Rafie IM, Hajar R. Contrast-induced Nephropathy. Heart Views. 2013;14:106-116. [PMID: 24696755 DOI: 10.4103/1995-705x.125926] [Cited by in Crossref: 87] [Cited by in F6Publishing: 36] [Article Influence: 10.9] [Reference Citation Analysis]
201 Stipinovic M, Percin L, Radonic V, Jerkic H, Jurin I, Letilovic T. Periprocedural myocardial and renal injury in patients undergoing elective percutaneous coronary interventions - is there an association? Medicine (Baltimore) 2019;98:e16989. [PMID: 31651833 DOI: 10.1097/MD.0000000000016989] [Reference Citation Analysis]
202 Sun G, Chen P, Wang K, Li H, Chen S, Liu J, He Y, Song F, Liu Y, Chen JY. Contrast-Induced Nephropathy and Long-Term Mortality After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction. Angiology 2019;70:621-6. [PMID: 30317864 DOI: 10.1177/0003319718803677] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
203 Joo C, Park E, Min JW, Kang H, Yoo DS, Jung HJ. Contrast Media-Induced Nephropathy in Patients with Unruptured Cerebral Aneurysm After Coiling Endovascular Treatment. World Neurosurg 2019;121:e39-44. [PMID: 30196168 DOI: 10.1016/j.wneu.2018.08.206] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
204 Fitts MK, Pike DB, Anderson K, Shiu YT. Hemodynamic Shear Stress and Endothelial Dysfunction in Hemodialysis Access. Open Urol Nephrol J 2014;7:33-44. [PMID: 25309636 DOI: 10.2174/1874303X01407010033] [Cited by in Crossref: 37] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
205 Lai HM, Aronow WS, Chugh SS, Pudasaini B, Goel A, Garrick R. Risk factors for hemodialysis and mortality in patients with contrast-induced nephropathy. Am J Ther 2013;20:607-12. [PMID: 22820714 DOI: 10.1097/MJT.0b013e31822831e9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
206 Abe M, Morimoto T, Nakagawa Y, Furukawa Y, Ono K, Kato T, Kadota K, Ando K, Ishii M, Masunaga N, Akao M, Kimura T. Impact of Transient or Persistent Contrast-induced Nephropathy on Long-term Mortality After Elective Percutaneous Coronary Intervention. The American Journal of Cardiology 2017;120:2146-53. [DOI: 10.1016/j.amjcard.2017.08.036] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
207 Stacul F. Reducing the Risks for Contrast-Induced Nephropathy. Cardiovasc Intervent Radiol 2005;28:S12-8. [DOI: 10.1007/s00270-005-0197-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
208 Mamas MA, Fath-ordoubadi F, Fraser DG. Telescoping catheter technique: looking towards the kidneys. Cardiovascular Revascularization Medicine 2011;12:123-8. [DOI: 10.1016/j.carrev.2009.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
209 Atanda AC, Olafiranye O. Contrast-induced acute kidney injury in interventional cardiology: Emerging evidence and unifying mechanisms of protection by remote ischemic conditioning. Cardiovasc Revasc Med 2017;18:549-53. [PMID: 28610773 DOI: 10.1016/j.carrev.2017.06.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
210 Kim JH, Yang JH, Choi SH, Song YB, Hahn JY, Choi JH, Lee SH, Gwon HC. Predictors of outcomes of contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic kidney disease. Am J Cardiol. 2014;114:1830-1835. [PMID: 25438909 DOI: 10.1016/j.amjcard.2014.09.022] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
211 Van Praet JT, De Vriese AS. Prevention of contrast-induced nephropathy: a critical review. Curr Opin Nephrol Hypertens 2007;16:336-47. [PMID: 17565276 DOI: 10.1097/MNH.0b013e3281ca6fe5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
212 Chillo P, Malaja NW, Kisenge P. Magnitude and associated factors of contrast induced nephropathy among patients undergoing coronary angiography and interventions at a cardiac referral hospital in Tanzania - a cross-sectional study. Pan Afr Med J 2021;38:311. [PMID: 34285734 DOI: 10.11604/pamj.2021.38.311.24536] [Reference Citation Analysis]
213 Markota D, Markota I, Starčević B, Tomić M, Prskalo Z, Brizić I. Prevention of contrast-induced nephropathy with Na/K citrate. European Heart Journal 2013;34:2362-7. [DOI: 10.1093/eurheartj/eht009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
214 Yoon HJ, Kim H, Lee JP, Choi SW, Cho HO, Shin HW, Park HS, Cho YK, Nam CW, Hur SH, Kim YN, Kim KB. The efficacy of the cystatin C based glomerular filtration rate in the estimation of safe contrast media volume. Korean Circ J 2013;43:622-7. [PMID: 24174963 DOI: 10.4070/kcj.2013.43.9.622] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
215 Khattak A, Mandel EI, Reynolds MR, Charytan DM. Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Stable Angina in Advanced CKD: A Decision Analysis. Am J Kidney Dis 2017;69:350-7. [PMID: 27646423 DOI: 10.1053/j.ajkd.2016.07.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
216 Reyes LF, Severiche-Bueno DF, Bustamante CA, Murillo S, Soni NJ, Poveda M, Gomez E, Buitrago R, Rodriguez A. Serum levels of neutrophil Gelatinase associated Lipocalin (NGAL) predicts hemodialysis after coronary angiography in high risk patients with acute coronary syndrome. BMC Nephrol 2020;21:143. [PMID: 32321453 DOI: 10.1186/s12882-020-01799-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
217 Hernández F, Mora L, García-tejada J, Velázquez M, Gómez-blázquez I, Bastante T, Albarrán A, Andreu J, Tascón J. Comparación de iodixanol frente a ioversol en la prevención de la nefropatía por contraste tras coronariografía o angioplastia en pacientes diabéticos. Revista Española de Cardiología 2009;62:1373-80. [DOI: 10.1016/s0300-8932(09)73122-7] [Cited by in Crossref: 12] [Article Influence: 0.9] [Reference Citation Analysis]
218 James MT, Hemmelgarn BR, Tonelli M. Early recognition and prevention of chronic kidney disease. Lancet. 2010;375:1296-1309. [PMID: 20382326 DOI: 10.1016/s0140-6736(09)62004-3] [Cited by in Crossref: 341] [Cited by in F6Publishing: 162] [Article Influence: 28.4] [Reference Citation Analysis]
219 Gupta A, Dosekun AK, Kumar V. Carbon dioxide-angiography for patients with peripheral arterial disease at risk of contrast-induced nephropathy. World J Cardiol 2020; 12(2): 76-90 [PMID: 32184976 DOI: 10.4330/wjc.v12.i2.76] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
220 Sgura FA, Bertelli L, Monopoli D, Leuzzi C, Guerri E, Spartà I, Politi L, Aprile A, Amato A, Rossi R, Biondi-Zoccai G, Sangiorgi GM, Modena MG. Mehran contrast-induced nephropathy risk score predicts short- and long-term clinical outcomes in patients with ST-elevation-myocardial infarction. Circ Cardiovasc Interv 2010;3:491-8. [PMID: 20923986 DOI: 10.1161/CIRCINTERVENTIONS.110.955310] [Cited by in Crossref: 73] [Cited by in F6Publishing: 21] [Article Influence: 6.1] [Reference Citation Analysis]
221 Zaytseva NV, Shamkhalova MS, Shestakova MV, Matskeplishvili ST, Tugeeva EF, Buziashvili UI, Deev AD, Dedov II. Contrast-induced nephropathy in patients with type 2 diabetes during coronary angiography: Risk-factors and prognostic value. Diabetes Research and Clinical Practice 2009;86:S63-9. [DOI: 10.1016/s0168-8227(09)70012-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
222 Liu J, Xie Y, He F, Gao Z, Hao Y, Zu X, Chang L, Li Y. Recombinant Brain Natriuretic Peptide for the Prevention of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease Undergoing Nonemergent Percutaneous Coronary Intervention or Coronary Angiography: A Randomized Controlled Trial. Biomed Res Int 2016;2016:5985327. [PMID: 26949703 DOI: 10.1155/2016/5985327] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
223 Martin DR. Nephrogenic system fibrosis: A radiologist's practical perspective. European Journal of Radiology 2008;66:220-4. [DOI: 10.1016/j.ejrad.2008.01.029] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
224 Yamamoto M, Hayashida K, Mouillet G, Chevalier B, Meguro K, Watanabe Y, Dubois-Rande JL, Morice MC, Lefèvre T, Teiger E. Renal function-based contrast dosing predicts acute kidney injury following transcatheter aortic valve implantation. JACC Cardiovasc Interv 2013;6:479-86. [PMID: 23702012 DOI: 10.1016/j.jcin.2013.02.007] [Cited by in Crossref: 80] [Cited by in F6Publishing: 66] [Article Influence: 10.0] [Reference Citation Analysis]
225 Miura D, Yamada Y, Kusaba S, Nogami E, Yunoki J, Sakamoto Y, Hikichi Y, Node K, Sakaguchi Y. Influence of preoperative serum creatinine level and intraoperative volume of contrast medium on the risk of acute kidney injury after transfemoral transcatheter aortic valve implantation: a retrospective observational study. BMC Res Notes 2019;12:484. [PMID: 31383003 DOI: 10.1186/s13104-019-4527-2] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
226 Khalfallah M, Abdelmageed R, Allaithy A. Very Early Versus Early Percutaneous Coronary Intervention in Patients with Decreased e-GFR after Successful Fibrinolytic Therapy. Glob Heart 2020;15:34. [PMID: 32489807 DOI: 10.5334/gh.794] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
227 Rim MY, Ro H, Kang WC, Kim AJ, Park H, Chang JH, Lee HH, Chung W, Jung JY. The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study. Am J Kidney Dis. 2012;60:576-582. [PMID: 22658321 DOI: 10.1053/j.ajkd.2012.04.017] [Cited by in Crossref: 40] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
228 Javanbakht M, Hemami MR, Mashayekhi A, Branagan-Harris M, Zaman A, Al-Najjar Y, O'Donoghue D, Fath-Ordoubadi F, Wheatcroft S. DyeVert™ PLUS EZ System for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Diagnostic Coronary Angiography and/or Percutaneous Coronary Intervention: A UK-Based Cost-Utility Analysis. Pharmacoecon Open 2020;4:459-72. [PMID: 31989464 DOI: 10.1007/s41669-020-00195-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
229 Yoshida S, Kamihata H, Nakamura S, Senoo T, Manabe K, Motohiro M, Sugiura T, Iwasaka T. Prevention of contrast-induced nephropathy by chronic pravastatin treatment in patients with cardiovascular disease and renal insufficiency. Journal of Cardiology 2009;54:192-8. [DOI: 10.1016/j.jjcc.2009.05.006] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
230 Gutierrez NM, Newhouse JH. Maximum Arterial Contrast Concentrations With Computed Tomography and Left Ventriculography: Implications for Contrast Nephrotoxicity Risk. Journal of Computer Assisted Tomography 2017;41:976-82. [DOI: 10.1097/rct.0000000000000624] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.4] [Reference Citation Analysis]
231 Sadat U, Usman A, Boyle JR, Hayes PD, Solomon RJ. Contrast Medium-Induced Acute Kidney Injury. Cardiorenal Med 2015;5:219-28. [PMID: 26195974 DOI: 10.1159/000430770] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
232 Balbir Singh G, Ann SH, Park J, Chung HC, Lee JS, Kim ES, Choi JI, Lee J, Kim SJ, Shin ES. Remote Ischemic Preconditioning for the Prevention of Contrast-Induced Acute Kidney Injury in Diabetics Receiving Elective Percutaneous Coronary Intervention. PLoS One 2016;11:e0164256. [PMID: 27723839 DOI: 10.1371/journal.pone.0164256] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
233 Ohno I, Hayashi H, Aonuma K, Horio M, Kashihara N, Okada H, Komatsu Y, Tamura S, Awai K, Yamashita Y, Kuwatsuru R, Hirayama A, Saito Y, Murohara T, Tamaki N, Sato A, Takayama T, Imai E, Yasuda Y, Koya D, Tsubakihara Y, Horie S, Korogi Y, Narumi Y, Hayakawa K, Daida H, Node K, Kubota I; Japanese Society of Nephrology., Japan Radiological Society., Japanese Circulation Society. Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version. JSN, JRS, and JCS Joint Working Group. Jpn J Radiol 2013;31:546-84. [PMID: 23884513 DOI: 10.1007/s11604-013-0226-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
234 Bainey KR, Rahim S, Etherington K, Rokoss ML, Natarajan MK, Velianou JL, Brons S, Mehta SR; CAPTAIN Investigators. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial. Am Heart J 2015;170:110-6. [PMID: 26093871 DOI: 10.1016/j.ahj.2015.04.019] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 6.7] [Reference Citation Analysis]
235 Shacham Y, Steinvil A, Arbel Y. Acute kidney injury among ST elevation myocardial infarction patients treated by primary percutaneous coronary intervention: a multifactorial entity. J Nephrol 2016;29:169-74. [PMID: 26861658 DOI: 10.1007/s40620-015-0255-4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 5.3] [Reference Citation Analysis]
236 Shacham Y, Gal-oz A, Leshem-rubinow E, Arbel Y, Flint N, Keren G, Roth A, Steinvil A. Association of Admission Hemoglobin Levels and Acute Kidney Injury Among Myocardial Infarction Patients Treated With Primary Percutaneous Intervention. Canadian Journal of Cardiology 2015;31:50-5. [DOI: 10.1016/j.cjca.2014.11.001] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
237 Liu JM, Xie YN, Gao ZH, Zu XG, Li YJ, Hao YM, Chang L. Brain natriuretic peptide for prevention of contrast-induced nephropathy after percutaneous coronary intervention or coronary angiography. Can J Cardiol 2014;30:1607-12. [PMID: 25418218 DOI: 10.1016/j.cjca.2014.08.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
238 Roghi A, Savonitto S, Cavallini C, Arraiz G, Angoli L, Castriota F, Bernardi G, Sansa M, De Servi S, Pitscheider W, Danzi GB, Reimers B, Klugmann S, Zaninotto M, Ardissino D. Impact of acute renal failure following percutaneous coronary intervention on long-term mortality. Journal of Cardiovascular Medicine 2008;9:375-81. [DOI: 10.2459/jcm.0b013e3282eee979] [Cited by in Crossref: 34] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
239 Hasan F, Bonatti J. Robotically assisted percutaneous coronary intervention: benefits to the patient and the cardiologist. Expert Review of Cardiovascular Therapy 2015;13:1165-8. [DOI: 10.1586/14779072.2015.1091725] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
240 Merdler I, Loewenstein I, Zahler D, Levit D, Hochstadt A, Banai S, Gal-Oz A, Shacham Y. Acute cardiorenal anemia syndrome among ST-elevation myocardial infarction patients treated by primary percutaneous intervention. Coron Artery Dis 2021;32:275-80. [PMID: 33060530 DOI: 10.1097/MCA.0000000000000973] [Reference Citation Analysis]
241 Cruz DN, Perazella MA, Ronco C. The role of extracorporeal blood purification therapies in the prevention of radiocontrast-induced nephropathy. Int J Artif Organs 2008;31:515-24. [PMID: 18609504 DOI: 10.1177/039139880803100607] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
242 Mehran R, Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney Int Suppl. 2006;S11-S15. [PMID: 16612394 DOI: 10.1038/sj.ki.5000368] [Cited by in Crossref: 446] [Cited by in F6Publishing: 372] [Article Influence: 27.9] [Reference Citation Analysis]
243 Conen D, Buerkle G, Perruchoud AP, Buettner HJ, Mueller C. Hypertension is an independent risk factor for contrast nephropathy after percutaneous coronary intervention. Int J Cardiol 2006;110:237-41. [PMID: 16298441 DOI: 10.1016/j.ijcard.2005.09.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
244 Heinrich MC, Häberle L, Müller V, Bautz W, Uder M. Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials. Radiology. 2009;250:68-86. [PMID: 19092091 DOI: 10.1148/radiol.2501080833] [Cited by in Crossref: 221] [Cited by in F6Publishing: 177] [Article Influence: 17.0] [Reference Citation Analysis]
245 Kinik M, Çamci S, Ari S, Ari H, Melek M, Bozat T. The effect of whole blood viscosity on contrast-induced nephropathy development in patients undergoing percutaneous coronary intervention. Postgrad Med 2021;:1-7. [PMID: 34670475 DOI: 10.1080/00325481.2021.1997007] [Reference Citation Analysis]
246 Brown JR, Solomon RJ, Robey RB, Plomondon ME, Maddox TM, Marshall EJ, Nichols EL, Matheny ME, Tsai TT, Rumsfeld JS, Lee RE, Sarnak MJ. Chronic Kidney Disease Progression and Cardiovascular Outcomes Following Cardiac Catheterization-A Population-Controlled Study. J Am Heart Assoc 2016;5:e003812. [PMID: 27742616 DOI: 10.1161/JAHA.116.003812] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
247 Bhandari S, Seth A, Sethi KK, Tyagi S, Gupta R, Tiwari SC, Mehrotra S, Seth A, Guha S, Deb PK, Dasbiswas A, Mohanan PP, Venugopal K, Sinha N, Pinto B, Banerjee A, Sengottuvelu G, Mehran R, Mc Collough P; Cardiological Society of India. Cardiological Society of India practice guidelines for angiography in patients with renal dysfunction. Indian Heart J 2012;64 Suppl 2:S18-43. [PMID: 23186627 DOI: 10.1016/j.ihj.2012.11.007] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
248 Rosenstock JL, Gilles E, Geller AB, Panagopoulos G, Mathew S, Malieckal D, Devita MV, Michelis MF. Impact of heart failure on the incidence of contrast-induced nephropathy in patients with chronic kidney disease. Int Urol Nephrol 2010;42:1049-54. [DOI: 10.1007/s11255-010-9798-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
249 Lentine KL, Hurst FP, Jindal RM, Villines TC, Kunz JS, Yuan CM, Hauptman PJ, Abbott KC. Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies. Am J Kidney Dis. 2010;55:152-167. [PMID: 19783341 DOI: 10.1053/j.ajkd.2009.06.032] [Cited by in Crossref: 69] [Cited by in F6Publishing: 47] [Article Influence: 5.3] [Reference Citation Analysis]
250 Karimi Galougahi K, Chadban S, Mehran R, Bangalore S, Chertow GM, Ali ZA. Invasive Management of Coronary Artery Disease in Advanced Renal Disease. Kidney Int Rep 2021;6:1513-24. [PMID: 34169192 DOI: 10.1016/j.ekir.2021.02.041] [Reference Citation Analysis]
251 Lodhia N, Kader M, Mayes T, Mantry P, Maliakkal B. Risk of contrast-induced nephropathy in hospitalized patients with cirrhosis. World J Gastroenterol 2009; 15(12): 1459-1464 [PMID: 19322918 DOI: 10.3748/wjg.15.1459] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
252 Smilowitz NR, Weisz G. Robotic-Assisted Angioplasty: Current Status and Future Possibilities. Curr Cardiol Rep 2012;14:642-6. [DOI: 10.1007/s11886-012-0300-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
253 Wahlgren CM, Malmstedt J. Outcomes of endovascular abdominal aortic aneurysm repair compared with open surgical repair in high-risk patients: Results from the Swedish Vascular Registry. Journal of Vascular Surgery 2008;48:1382-8. [DOI: 10.1016/j.jvs.2008.07.009] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
254 Loomba RS, Shah PH, Aggarwal S, Arora RR. Role of N-Acetylcysteine to Prevent Contrast-Induced Nephropathy: A Meta-analysis. American Journal of Therapeutics 2016;23:e172-83. [DOI: 10.1097/mjt.0b013e31829dbc1c] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
255 Erley C. [Iodinated contrast agent-induced nephropathy]. Radiologe 2007;47:761-7. [PMID: 17823784 DOI: 10.1007/s00117-007-1549-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
256 An JN, Yoo KD, Hwang JH, Kim H, Kim S, Yang SH, Kim JH, Kim DK, Oh YK, Kim YS, Lim CS, Lee JP. Circulating tumour necrosis factor receptors 1 and 2 predict contrast-induced nephropathy and progressive renal dysfunction: A prospective cohort study: TNF receptors in CIN and renal deterioration. Nephrology 2015;20:552-9. [DOI: 10.1111/nep.12448] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
257 Xinwei J, Xianghua F, Jing Z, Xinshun G, Ling X, Weize F, Guozhen H, Yunfa J, Weili W, Shiqiang L. Comparison of Usefulness of Simvastatin 20 mg Versus 80 mg in Preventing Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. The American Journal of Cardiology 2009;104:519-24. [DOI: 10.1016/j.amjcard.2009.04.014] [Cited by in Crossref: 90] [Cited by in F6Publishing: 83] [Article Influence: 6.9] [Reference Citation Analysis]
258 Cicin I, Erdogan B, Gulsen E, Uzunoglu S, Sut N, Turkmen E, Kodaz H, Ustundag S. Incidence of contrast-induced nephropathy in hospitalised patients with cancer. Eur Radiol 2014;24:184-90. [PMID: 24220752 DOI: 10.1007/s00330-013-2996-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 3.7] [Reference Citation Analysis]
259 Hsieh MS, Chiu CS, How CK, Chiang JH, Sheu ML, Chen WC, Lin HJ, Hsieh VC, Hu SY. Contrast Medium Exposure During Computed Tomography and Risk of Development of End-Stage Renal Disease in Patients With Chronic Kidney Disease: A Nationwide Population-Based, Propensity Score-Matched, Longitudinal Follow-Up Study. Medicine (Baltimore) 2016;95:e3388. [PMID: 27100424 DOI: 10.1097/MD.0000000000003388] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
260 Huber W, Huber T, Baum S, Franzen M, Schmidt C, Stadlbauer T, Beitz A, Schmid RM, Schmid S. Sodium Bicarbonate Prevents Contrast-Induced Nephropathy in Addition to Theophylline: A Randomized Controlled Trial. Medicine (Baltimore) 2016;95:e3720. [PMID: 27227933 DOI: 10.1097/MD.0000000000003720] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
261 Ding Y, Niu J, Fan J, Liu Y. Repeated mechanical thrombectomy for acute ischemic stroke in a dialysis patient: A case report and literature review. Hemodialysis International 2019;24. [DOI: 10.1111/hdi.12811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
262 Van Biesen W, Vanholder R, Lameire N. Defining Acute Renal Failure: RIFLE and Beyond: Table 1. CJASN 2006;1:1314-9. [DOI: 10.2215/cjn.02070606] [Cited by in Crossref: 89] [Cited by in F6Publishing: 34] [Article Influence: 5.6] [Reference Citation Analysis]
263 Ebisawa S, Kurita T, Tanaka N, Nasu K, Kimura M, Ito T, Kinoshita Y, Tsuchikane E, Terashima M, Suzuki T. Impact of minimum contrast media volumes during elective percutaneous coronary intervention for prevention of contrast-induced nephropathy in patients with stable coronary artery disease. Cardiovasc Interv and Ther 2016;31:13-20. [DOI: 10.1007/s12928-015-0337-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
264 Song HY, Wei CM, Zhou WX, Hu HF, Wan QJ. Association between admission hemoglobin level and prognosis in patients with type 2 diabetes mellitus. World J Diabetes 2021; 12(11): 1917-1927 [PMID: 34888016 DOI: 10.4239/wjd.v12.i11.1917] [Reference Citation Analysis]
265 Sendeski M, Patzak A, Pallone TL, Cao C, Persson AE, Persson PB. Iodixanol, constriction of medullary descending vasa recta, and risk for contrast medium-induced nephropathy. Radiology 2009;251:697-704. [PMID: 19366904 DOI: 10.1148/radiol.2513081732] [Cited by in Crossref: 80] [Cited by in F6Publishing: 72] [Article Influence: 6.2] [Reference Citation Analysis]
266 Owen RJ, Hiremath S, Myers A, Fraser-Hill M, Barrett BJ. Canadian Association of Radiologists consensus guidelines for the prevention of contrast-induced nephropathy: update 2012. Can Assoc Radiol J. 2014;65:96-105. [PMID: 24559602 DOI: 10.1016/j.carj.2012.11.002] [Cited by in Crossref: 87] [Cited by in F6Publishing: 77] [Article Influence: 10.9] [Reference Citation Analysis]
267 Barbieri L, Verdoia M, Schaffer A, Niccoli G, Perrone-filardi P, Bellomo G, Marino P, Suryapranata H, Luca GD. Elevated Homocysteine and the Risk of Contrast-Induced Nephropathy: A Cohort Study. Angiology 2015;66:333-8. [DOI: 10.1177/0003319714533401] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
268 Armijo G, Estevez-loureiro R, Carrasco-chinchilla F, Arzamendi D, Fernández-vázquez F, Jimenez-quevedo P, Freixa X, Pascual I, Serrador AM, Mesa D, Alonso-briales JH, Goicolea J, Hernández-antolin R, Fernández-peregrina E, Cid Alvarez AB, Andraka L, Cruz-gonzalez I, Berenguer A, Sanchis J, Diez Gil JL, Hernández-garcía JM, Li C, Benito-gonzález T, de Agustin JA, Avanzas P, Regueiro A, Amat-santos I, Pan M, Nombela-franco L. Acute Kidney Injury After Percutaneous Edge-to-Edge Mitral Repair. Journal of the American College of Cardiology 2020;76:2463-73. [DOI: 10.1016/j.jacc.2020.09.582] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
269 Sudarsky D, Nikolsky E. Contrast-induced nephropathy in interventional cardiology. Int J Nephrol Renovasc Dis 2011;4:85-99. [PMID: 21912486 DOI: 10.2147/IJNRD.S21393] [Cited by in Crossref: 3] [Cited by in F6Publishing: 12] [Article Influence: 0.3] [Reference Citation Analysis]
270 Thomson VS, Narayanan K, Singh JC. Contrast induced nephropathy in urology. Indian J Urol. 2009;25:437-445. [PMID: 19955665 DOI: 10.4103/0970-1591.57904] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
271 Shoukat S, Gowani SA, Jafferani A, Dhakam SH. Contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Cardiol Res Pract 2010;2010:649164. [PMID: 20886058 DOI: 10.4061/2010/649164] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
272 Milia DJ, Brasel K. Current Use of CT in the Evaluation and Management of Injured Patients. Surgical Clinics of North America 2011;91:233-48. [DOI: 10.1016/j.suc.2010.10.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
273 Endre ZH. Acute Kidney Injury: Definitions and New Paradigms. Advances in Chronic Kidney Disease 2008;15:213-21. [DOI: 10.1053/j.ackd.2008.04.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
274 James MT, Wilton SB, Clement FM, Ghali WA, Knudtson ML, Tan Z, Tonelli M, Hemmelgarn BR, Norris CM; Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) and Alberta Kidney Disease Network (AKDN) Investigators. Kidney Function Does Not Modify the Favorable Quality of Life Changes Associated With Revascularization for Coronary Artery Disease: Cohort Study. J Am Heart Assoc 2016;5:e003642. [PMID: 27436303 DOI: 10.1161/JAHA.116.003642] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
275 Ryan MJ, Tuttle KR. Elevations in serum creatinine with RAAS blockade: why isn't it a sign of kidney injury? Curr Opin Nephrol Hypertens 2008;17:443-9. [PMID: 18695383 DOI: 10.1097/MNH.0b013e32830a9606] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
276 Kimura T, Obi Y, Yasuda K, Sasaki K, Takeda Y, Nagai Y, Imai E, Rakugi H, Isaka Y, Hayashi T. Effects of chronic kidney disease and post-angiographic acute kidney injury on long-term prognosis after coronary artery angiography. Nephrol Dial Transplant 2011;26:1838-46. [PMID: 20940369 DOI: 10.1093/ndt/gfq631] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
277 Meinel FG, De Cecco CN, Schoepf UJ, Katzberg R. Contrast-induced acute kidney injury: definition, epidemiology, and outcome. Biomed Res Int 2014;2014:859328. [PMID: 24734250 DOI: 10.1155/2014/859328] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
278 Endre ZH. Nephrogenic systemic fibrosis: is any contrast safe in renal failure? Internal Medicine Journal 2007;37:429-31. [DOI: 10.1111/j.1445-5994.2007.01401.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
279 Ma M, Wan X, Gao M, Pan B, Chen D, Sun Q, Zhang M, Zhou C, Li T, Pan H, Shao W, Liu Z, Chen Y, Cao C. Renin-angiotensin-aldosterone system blockade is associated with higher risk of contrast-induced acute kidney injury in patients with diabetes. Aging (Albany NY) 2020;12:5858-77. [PMID: 32241961 DOI: 10.18632/aging.102982] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
280 Klein LW, Sheldon MW, Brinker J, Mixon TA, Skelding K, Strunk AO, Tommaso CL, Weiner B, Bailey SR, Uretsky B. The use of radiographic contrast media during PCI: a focused review: a position statement of the Society of Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2009;74:728-746. [PMID: 19830793 DOI: 10.1002/ccd.22113] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
281 Stolker JM, McCullough PA, Rao S, Inzucchi SE, Spertus JA, Maddox TM, Masoudi FA, Xiao L, Kosiborod M. Pre-procedural glucose levels and the risk for contrast-induced acute kidney injury in patients undergoing coronary angiography. J Am Coll Cardiol 2010;55:1433-40. [PMID: 20359592 DOI: 10.1016/j.jacc.2009.09.072] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 4.3] [Reference Citation Analysis]
282 Chang H, Kim YL, Hassan A, Fitzgerald PJ. Whole blood reflectance for assessment of hematologic condition and detection of angiographic contrast media. Appl Opt 2009;48:2435. [DOI: 10.1364/ao.48.002435] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
283 Sakai K, Ikari Y, Nanasato M, Umetsu H, Okutsu M, Takikawa T, Sumitsuji S, Sadamatsu K, Takada M, Kato Y, Ogasawara N, Otowa K. Impact of intravascular ultrasound-guided minimum-contrast coronary intervention on 1-year clinical outcomes in patients with stage 4 or 5 advanced chronic kidney disease. Cardiovasc Interv and Ther 2019;34:234-41. [DOI: 10.1007/s12928-018-0552-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
284 Yang SY, Chiou TT, Shiao CC, Lin HY, Chan MJ, Wu CH, Sun CY, Wang WJ, Huang YT, Wu VC, Chen YC, Fang JT, Hwang SJ, Pan HC. Nomenclature and diagnostic criteria for acute kidney injury - 2020 consensus of the Taiwan AKI-task force. J Formos Med Assoc 2021:S0929-6646(21)00363-6. [PMID: 34446340 DOI: 10.1016/j.jfma.2021.08.005] [Reference Citation Analysis]
285 Au TH, Bruckner A, Mohiuddin SM, Hilleman DE. The Prevention of Contrast-Induced Nephropathy. Ann Pharmacother 2014;48:1332-42. [DOI: 10.1177/1060028014541996] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 4.1] [Reference Citation Analysis]
286 Zhang JY, Wang Q, Wang RT, Li F, Cheng HX, Lian K, Liu Y, Tao L. Increased urinary adiponectin level is associated with contrast-induced nephropathy in patients undergoing elective percutaneous coronary intervention. BMC Cardiovasc Disord 2019;19:160. [PMID: 31269899 DOI: 10.1186/s12872-019-1143-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
287 Blankenship JC. Double jeopardy, double trouble. Catheter Cardiovasc Interv 2010;76:279-80. [PMID: 20665877 DOI: 10.1002/ccd.22709] [Reference Citation Analysis]
288 Leistner DM, Münch C, Steiner J, Erbay A, Riedel M, Gebhard C, Lauten A, Landmesser U, Stähli BE. Impact of acute kidney injury in elderly (≥80 years) patients undergoing percutaneous coronary intervention. J Interven Cardiol 2018;31:792-8. [DOI: 10.1111/joic.12547] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
289 El-Menyar AA, Al Suwaidi J, Holmes DR Jr. Use of drug-eluting stents in patients with coronary artery disease and renal insufficiency. Mayo Clin Proc 2010;85:165-71. [PMID: 20118392 DOI: 10.4065/mcp.2009.0314] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
290 Isaka Y, Hayashi H, Aonuma K, Horio M, Terada Y, Doi K, Fujigaki Y, Yasuda H, Sato T, Fujikura T, Kuwatsuru R, Toei H, Murakami R, Saito Y, Hirayama A, Murohara T, Sato A, Ishii H, Takayama T, Watanabe M, Awai K, Oda S, Murakami T, Yagyu Y, Joki N, Komatsu Y, Miyauchi T, Ito Y, Miyazawa R, Kanno Y, Ogawa T, Koshi E, Kosugi T, Yasuda Y;  Japanese Society of Nephrology; Japan Radiological Society;  and Japanese Circulation Society Joint Working Group. Guideline on the use of iodinated contrast media in patients with kidney disease 2018. Clin Exp Nephrol. 2020;24:1-44. [PMID: 31709463 DOI: 10.1007/s10157-019-01750-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
291 Abdelghani M, Soliman OI, Schultz C, Vahanian A, Serruys PW. Adjudicating paravalvular leaks of transcatheter aortic valves: a critical appraisal. Eur Heart J 2016;37:2627-44. [DOI: 10.1093/eurheartj/ehw115] [Cited by in Crossref: 25] [Cited by in F6Publishing: 12] [Article Influence: 4.2] [Reference Citation Analysis]
292 Bentley ML, Corwin HL, Dasta J. Drug-induced acute kidney injury in the critically ill adult: Recognition and prevention strategies: . Critical Care Medicine 2010;38:S169-74. [DOI: 10.1097/ccm.0b013e3181de0c60] [Cited by in Crossref: 59] [Cited by in F6Publishing: 16] [Article Influence: 4.9] [Reference Citation Analysis]
293 Roy P, Raya V, Okabe T, Pinto Slottow TL, Steinberg DH, Smith K, Xue Z, Satler LF, Kent KM, Suddath WO. Incidence, predictors, and outcomes of post-percutaneous coronary intervention nephropathy in patients with diabetes mellitus and normal baseline serum creatinine levels. Am J Cardiol. 2008;101:1544-1549. [PMID: 18489931 DOI: 10.1016/j.amjcard.2008.02.035] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
294 Nakamura T, Sugaya T, Node K, Ueda Y, Koide H. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. Am J Kidney Dis 2006;47:439-44. [PMID: 16490622 DOI: 10.1053/j.ajkd.2005.11.006] [Cited by in Crossref: 101] [Cited by in F6Publishing: 83] [Article Influence: 6.3] [Reference Citation Analysis]
295 Petek BJ, Bravo PE, Kim F, de Boer IH, Kudenchuk PJ, Shuman WP, Gunn ML, Carlbom DJ, Gill EA, Maynard C, Branch KR. Incidence and Risk Factors for Postcontrast Acute Kidney Injury in Survivors of Sudden Cardiac Arrest. Ann Emerg Med 2016;67:469-476.e1. [PMID: 26363571 DOI: 10.1016/j.annemergmed.2015.07.516] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
296 McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol. 2008;51:1419-1428. [PMID: 18402894 DOI: 10.1016/j.jacc.2007.12.035] [Cited by in Crossref: 629] [Cited by in F6Publishing: 534] [Article Influence: 44.9] [Reference Citation Analysis]
297 Takeuchi T, Isobe S, Sato K, Kato MI, Kasai NN, Ohyama H, Yoshikawa D, Ishii H, Matsubara T, Murohara T. Cystatin C: a possible sensitive marker for detecting potential kidney injury after computed tomography coronary angiography. J Comput Assist Tomogr. 2011;35:240-245. [PMID: 21412097 DOI: 10.1097/rct.0b013e31820a9465] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
298 Pucelikova T, Dangas G, Mehran R. Contrast-induced nephropathy. Catheter Cardiovasc Interv 2008;71:62-72. [PMID: 17975790 DOI: 10.1002/ccd.21207] [Cited by in Crossref: 63] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
299 Eisenhart E, Benson S, Lacombe P, Himmelfarb J, Zimmerman R, Schimelman B, Parker MG. Safety of Low Volume Iodinated Contrast Administration for Arteriovenous Fistula Intervention in Chronic Kidney Disease Stage 4 or 5 Utilizing a Bicarbonate Prophylaxis Strategy: CONTRAST ADMINISTRATION IN AVF INTERVENTION. Seminars in Dialysis 2010;23:638-42. [DOI: 10.1111/j.1525-139x.2010.00800.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
300 Celik O, Ozturk D, Akin F, Ayca B, Yalcın AA, Erturk M, Bıyık I, Ayaz A, Akturk IF, Enhos A, Aslan S. Association Between Contrast Media Volume-Glomerular Filtration Rate Ratio and Contrast-Induced Acute Kidney Injury After Primary Percutaneous Coronary Intervention. Angiology 2015;66:519-24. [PMID: 25005762 DOI: 10.1177/0003319714542277] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
301 Jia KQ, Blais D, Porter K, Boudoulas KD, Lilly S. The effect of establishing pre-angiography thresholds on contrast utilization. J Interv Cardiol 2018;31:430-5. [PMID: 29266400 DOI: 10.1111/joic.12482] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
302 Aktürk E, Aşkın L, Taşolar H, Kurtoğlu E, Türkmen S, Tanrıverdi O, Uzel KE. Evaluation of contrast nephropathy in percutaneous treatment of chronic total occlusions. Interv Med Appl Sci 2019;11:95-100. [PMID: 32148912 DOI: 10.1556/1646.11.2019.15] [Reference Citation Analysis]
303 Shoji S, Sawano M, Sandhu AT, Heidenreich PA, Shiraishi Y, Noma S, Suzuki M, Numasawa Y, Fukuda K, Kohsaka S. Evidence-to-Practice Gap for Preventing Procedure-Related Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention. J Am Heart Assoc 2021;10:e020047. [PMID: 34310187 DOI: 10.1161/JAHA.120.020047] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
304 Liu Y, He YT, Tan N, Chen JY, Liu YH, Yang DH, Huang SJ, Ye P, Li HL, Ran P, Duan CY, Chen SQ, Zhou YL, Chen PY. Preprocedural N-terminal pro-brain natriuretic peptide (NT-proBNP) is similar to the Mehran contrast-induced nephropathy (CIN) score in predicting CIN following elective coronary angiography. J Am Heart Assoc 2015;4:e001410. [PMID: 25888371 DOI: 10.1161/JAHA.114.001410] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
305 Kayan M, Demirtas H, Türker Y, Kayan F, Çetinkaya G, Kara M, Orhan Çelik A, Umul A, Yılmaz Ö, Recep Aktaş A. Carotid and cerebral CT angiography using low volume of iodinated contrast material and low tube voltage. Diagn Interv Imaging 2016;97:1173-9. [PMID: 27421672 DOI: 10.1016/j.diii.2016.06.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
306 Giacoppo D, Gargiulo G, Buccheri S, Aruta P, Byrne RA, Cassese S, Dangas G, Kastrati A, Mehran R, Tamburino C, Capodanno D. Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Procedures: Evidence From a Hierarchical Bayesian Network Meta-Analysis of 124 Trials and 28 240 Patients. Circ Cardiovasc Interv 2017;10:e004383. [PMID: 28487354 DOI: 10.1161/CIRCINTERVENTIONS.116.004383] [Cited by in Crossref: 35] [Cited by in F6Publishing: 4] [Article Influence: 8.8] [Reference Citation Analysis]
307 McCullough PA, Brown JR. Effects of Intra-Arterial and Intravenous Iso-Osmolar Contrast Medium (Iodixanol) on the Risk of Contrast-Induced Acute Kidney Injury: A Meta-Analysis. Cardiorenal Med 2011;1:220-34. [PMID: 22164156 DOI: 10.1159/000332384] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
308 LaBounty TM, Shah M, Raman SV, Lin FY, Berman DS, Min JK. Within-hospital and 30-day outcomes in 107,994 patients undergoing invasive coronary angiography with different low-osmolar iodinated contrast media. Am J Cardiol 2012;109:1594-9. [PMID: 22440116 DOI: 10.1016/j.amjcard.2012.01.380] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
309 Ali ZA, Karimi Galougahi K, Nazif T, Maehara A, Hardy MA, Cohen DJ, Ratner LE, Collins MB, Moses JW, Kirtane AJ, Stone GW, Karmpaliotis D, Leon MB. Imaging- and physiology-guided percutaneous coronary intervention without contrast administration in advanced renal failure: a feasibility, safety, and outcome study. Eur Heart J 2016;37:3090-5. [PMID: 26957421 DOI: 10.1093/eurheartj/ehw078] [Cited by in Crossref: 91] [Cited by in F6Publishing: 72] [Article Influence: 15.2] [Reference Citation Analysis]
310 Planer D, Mehran R, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Möckel M, Reyes SL, Stone GW. Prognostic utility of left ventricular end-diastolic pressure in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 2011;108:1068-74. [PMID: 21798494 DOI: 10.1016/j.amjcard.2011.06.007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
311 Celik IE, Kurtul A, Duran M, Yarlioglues M, Elcik D, Kilic A, Koseoglu C, Oksuz F, Murat SN. Elevated serum fibrinogen levels and risk of contrast-induced acute kidney injury in patients undergoing a percutaneous coronary intervention for the treatment of acute coronary syndrome. Coron Artery Dis 2016;27:13-8. [PMID: 26267748 DOI: 10.1097/MCA.0000000000000295] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
312 Palli E, Makris D, Papanikolaou J, Garoufalis G, Zakynthinos E. Contrast-induced nephropathy in aged critically ill patients. Oxid Med Cell Longev 2014;2014:756469. [PMID: 24672639 DOI: 10.1155/2014/756469] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
313 Kiski D, Stepper W, Brand E, Breithardt G, Reinecke H. Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial. Nephrol Dial Transplant 2010;25:759-64. [PMID: 19903660 DOI: 10.1093/ndt/gfp582] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
314 Karamasis GV, Hampton-till J, Al-janabi F, Mohdnazri S, Parker M, Ioannou A, Jagathesan R, Kabir A, Sayer JW, Robinson NM, Aggarwal RK, Clesham GJ, Gamma RA, Kelly PA, Tang KH, Davies JR, Keeble T. Impact of point-of-care pre-procedure creatinine and eGFR testing in patients with ST segment elevation myocardial infarction undergoing primary PCI: The pilot STATCREAT study. International Journal of Cardiology 2017;240:8-13. [DOI: 10.1016/j.ijcard.2017.03.147] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
315 You Z, Guo T, Lin F, Lin C, Chen J, Li X, Chen Y, Lin K. Fibrinogen-to-Albumin Ratio Predicts Contrast-Induced Nephropathy in Patients after Emergency Percutaneous Coronary Intervention. Cardiol Res Pract 2019;2019:8260583. [PMID: 31827921 DOI: 10.1155/2019/8260583] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
316 Saji K, Namiuchi S, Sugie T, Takii T, Kato A. Irreversible deterioration of estimated glomerular filtration rate in patients with acute myocardial infarction after primary percutaneous coronary intervention. Cardiovasc Interv Ther 2017;32:318-24. [PMID: 27435738 DOI: 10.1007/s12928-016-0412-2] [Reference Citation Analysis]
317 Nozue T, Michishita I, Iwaki T, Mizuguchi I, Miura M. Contrast medium volume to estimated glomerular filtration rate ratio as a predictor of contrast-induced nephropathy developing after elective percutaneous coronary intervention. J Cardiol 2009;54:214-20. [PMID: 19782258 DOI: 10.1016/j.jjcc.2009.05.008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
318 Neyra JA, Shah S, Mooney R, Jacobsen G, Yee J, Novak JE. Contrast-induced acute kidney injury following coronary angiography: a cohort study of hospitalized patients with or without chronic kidney disease. Nephrol Dial Transplant 2013;28:1463-71. [PMID: 23585585 DOI: 10.1093/ndt/gft082] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
319 Rosenstock JL, Bruno R, Kim JK, Lubarsky L, Schaller R, Panagopoulos G, DeVita MV, Michelis MF. The effect of withdrawal of ACE inhibitors or angiotensin receptor blockers prior to coronary angiography on the incidence of contrast-induced nephropathy. Int Urol Nephrol. 2008;40:749-755. [PMID: 18438718 DOI: 10.1007/s11255-008-9368-1] [Cited by in Crossref: 60] [Cited by in F6Publishing: 46] [Article Influence: 4.3] [Reference Citation Analysis]
320 Toprak O. Risk Markers for Contrast-Induced Nephropathy. The American Journal of the Medical Sciences 2007;334:283-90. [DOI: 10.1097/maj.0b013e318068ddf9] [Cited by in Crossref: 44] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
321 Kanbay M, Covic A, Coca SG, Turgut F, Akcay A, Parikh CR. Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials. Int Urol Nephrol. 2009;41:617-627. [PMID: 19396567 DOI: 10.1007/s11255-009-9569-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
322 Watabe H, Sato A, Hoshi T, Takeyasu N, Abe D, Akiyama D, Kakefuda Y, Nishina H, Noguchi Y, Aonuma K. Association of contrast-induced acute kidney injury with long-term cardiovascular events in acute coronary syndrome patients with chronic kidney disease undergoing emergent percutaneous coronary intervention. Int J Cardiol 2014;174:57-63. [PMID: 24726211 DOI: 10.1016/j.ijcard.2014.03.146] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 6.8] [Reference Citation Analysis]
323 Hanna EB, Chen AY, Roe MT, Wiviott SD, Fox CS, Saucedo JF. Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction and chronic kidney disease undergoing percutaneous coronary intervention. JACC Cardiovasc Interv. 2011;4:1002-1008. [PMID: 21939940 DOI: 10.1016/j.jcin.2011.05.022] [Cited by in Crossref: 62] [Cited by in F6Publishing: 47] [Article Influence: 6.2] [Reference Citation Analysis]
324 Kim SJ, Choi D, Ko Y, Kim J, Han SH, Kim B, Kang S, Hong M, Jang Y, Choi KH, Yoo T. Relation of Homocysteinemia to Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention. The American Journal of Cardiology 2011;108:1086-91. [DOI: 10.1016/j.amjcard.2011.06.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
325 Powell SP, Chawla R, Bottinor W, Turlington J, Hopkinson DA, Patel K, Danyi P, Jovin IS. Race, contrast-induced nephropathy and long-term outcomes after coronary and peripheral angiography and intervention. Cardiovasc Revasc Med 2018;19:31-5. [PMID: 29980377 DOI: 10.1016/j.carrev.2018.06.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
326 Beyazal H, Caliskan Z, Utaç C. Comparison of effects of isotonic sodium chloride with diltiazem in prevention of contrast-induced nephropathy. Ren Fail 2014;36:351-5. [PMID: 24341598 DOI: 10.3109/0886022X.2013.866016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
327 Goo JJ, Kim JJ, Kang JH, Kim KN, Byun KS, Kim MK, Kim TI. Effect of renin-angiotensin-system blockers on contrast-medium-induced acute kidney injury after coronary angiography. Korean J Intern Med 2014;29:203-9. [PMID: 24648803 DOI: 10.3904/kjim.2014.29.2.203] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
328 ACT Investigators. Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT). Circulation. 2011;124:1250-1259. [PMID: 21859972 DOI: 10.1161/circulationaha.111.038943] [Cited by in Crossref: 238] [Cited by in F6Publishing: 68] [Article Influence: 21.6] [Reference Citation Analysis]
329 Kim KS, Kim K, Hwang SS, Jo YH, Lee CC, Kim TY, Rhee JE, Suh GJ, Singer AJ, Kim HD. Risk stratification nomogram for nephropathy after abdominal contrast-enhanced computed tomography. The American Journal of Emergency Medicine 2011;29:412-7. [DOI: 10.1016/j.ajem.2009.11.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
330 Liu YH, Liu Y, Duan CY, Tan N, Chen JY, Zhou YL, Li LW, He PC. Statins for the Prevention of Contrast-Induced Nephropathy After Coronary Angiography/Percutaneous Interventions: A Meta-analysis of Randomized Controlled Trials. J Cardiovasc Pharmacol Ther 2015;20:181-92. [PMID: 25193735 DOI: 10.1177/1074248414549462] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
331 Lee KH, Lee SR, Kang KP, Kim HJ, Lee SH, Rhee KS, Chae JK, Kim WH, Ko JK. Periprocedural hemoglobin drop and contrast-induced nephropathy in percutaneous coronary intervention patients. Korean Circ J 2010;40:68-73. [PMID: 20182591 DOI: 10.4070/kcj.2010.40.2.68] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
332 Weisz G, Smilowitz NR, Moses JW, Rabbani LE, Collins MB, Herscovici A, Jeron A, Leon MB, Luchner A. Magnetic positioning system in coronary angiography and percutaneous intervention: a feasibility and safety study. Catheter Cardiovasc Interv 2013;82:1084-90. [PMID: 23592312 DOI: 10.1002/ccd.24946] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
333 Di Serafino L, Turturo M, Lanzone S, Marano M, Scognamiglio G, Trimarco B, Cirillo P, Esposito G, D'Agostino C. Comparison of the Effect of Dual-Axis Rotational Coronary Angiography Versus Conventional Coronary Angiography on Frequency of Acute Kidney Injury, X-Ray Exposure Time, and Quantity of Contrast Medium Injected. Am J Cardiol 2018;121:1046-50. [PMID: 29519544 DOI: 10.1016/j.amjcard.2018.01.028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
334 Sinert R, Brandler E, Subramanian RA, Miller AC, Goldstein J. Does the Current Definition of Contrast-induced Acute Kidney Injury Reflect a True Clinical Entity? Acad Emerg Med 2012;19:1261-7. [DOI: 10.1111/acem.12011] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
335 Elcik D, Kelesoglu S, Yilmaz Y, Cetinkaya Z, Sulaiman J, Yurt R, Neselioglu S, Erel O, Inanc MT, Oguzhan A. Relationship between thiol, disulphide volume and contrast-induced nephropathy in acute coronary syndrome patients treated with percutaneous coronary intervention. Scandinavian Journal of Clinical and Laboratory Investigation 2021;81:173-80. [DOI: 10.1080/00365513.2021.1878386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
336 Hou J, Yan G, Liu B, Zhu B, Qiao Y, Wang D, Li R, Luo E, Tang C. The Protective Effects of Enalapril Maleate and Folic Acid Tablets against Contrast-Induced Nephropathy in Diabetic Rats. Biomed Res Int 2018;2018:4609750. [PMID: 29560361 DOI: 10.1155/2018/4609750] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
337 Faggioni M, Mehran R. Preventing Contrast-induced Renal Failure: A Guide. Interv Cardiol 2016;11:98-104. [PMID: 29588714 DOI: 10.15420/icr.2016:10:2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
338 Kewcharoen J, Yi R, Trongtorsak A, Prasitlumkum N, Mekraksakit P, Vutthikraivit W, Kanjanauthai S. Pre-Procedural Hyperglycemia Increases the Risk of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Systematic Review and Meta-Analysis. Cardiovasc Revasc Med 2020;21:1377-85. [PMID: 32402789 DOI: 10.1016/j.carrev.2020.04.040] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
339 Schilp J, de Blok C, Langelaan M, Spreeuwenberg P, Wagner C. Guideline adherence for identification and hydration of high-risk hospital patients for contrast-induced nephropathy. BMC Nephrol 2014;15:2. [PMID: 24393347 DOI: 10.1186/1471-2369-15-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
340 Gholoobi A, Sajjadi SM, Shabestari MM, Eshraghi A, Shamloo AS. The Impact of Remote Ischemic Pre-Conditioning on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography and Angioplasty: A Double-Blind Randomized Clinical Trial. Electron Physician 2015;7:1557-65. [PMID: 26816582 DOI: 10.19082/1557] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
341 Hernández F, Mora L, García-Tejada J, Velázquez M, Gómez-Blázquez I, Bastante T, Albarrán A, Andreu J, Tascón J. Comparison of iodixanol and ioversol for the prevention of contrast-induced nephropathy in diabetic patients after coronary angiography or angioplasty. Rev Esp Cardiol 2009;62:1373-80. [PMID: 20038403 DOI: 10.1016/s1885-5857(09)73531-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 0.1] [Reference Citation Analysis]
342 Nie B, Cheng WJ, Li YF, Cao Z, Yang Q, Zhao YX, Guo YH, Zhou YJ. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention. Catheter Cardiovasc Interv. 2008;72:958-965. [PMID: 19021282 DOI: 10.1002/ccd.21713] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
343 Lin C, Lin K, Guo Y, You Z, Zheng W, Lin F, Guo T, Zhu P. Low free triiodothyronine is associated with contrast-induced acute kidney injury and long-term outcome in elderly patients who underwent percutaneous coronary intervention. Anatol J Cardiol 2019;21:60-7. [PMID: 30694798 DOI: 10.14744/AnatolJCardiol.2018.38228] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
344 Luo E, Wang D, Liu B, Hou J, Yan G, Tang C. The Value of d-Dimer Level in Predicting Contrast-Induced Acute Kidney Injury in Patients With Acute ST-Segment Elevation Myocardial Infarction After PCI. Clin Appl Thromb Hemost 2020;26:1076029620944492. [PMID: 33032448 DOI: 10.1177/1076029620944492] [Reference Citation Analysis]
345 James MT, Tonelli M, Ghali WA, Knudtson ML, Faris P, Manns BJ, Pannu N, Galbraith PD, Hemmelgarn BR; Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease and Alberta Kidney Disease Network Investigators. Renal outcomes associated with invasive versus conservative management of acute coronary syndrome: propensity matched cohort study. BMJ 2013;347:f4151. [PMID: 23833076 DOI: 10.1136/bmj.f4151] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
346 Li H, Huang S, He Y, Liu Y, Liu Y, Chen J, Zhou Y, Tan N, Duan C, Chen P. Impact of an Early Decrease in Systolic Blood Pressure on The Risk of Contrast-Induced Nephropathy after Percutaneous Coronary Intervention. Heart, Lung and Circulation 2016;25:118-23. [DOI: 10.1016/j.hlc.2015.07.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]